https://investors.puretechhealth.com/ 2025-08-29T14:59:41-04:00 daily 1.0 https://investors.puretechhealth.com/committee-details/audit-committee 2024-08-22T02:07:03-04:00 0.5 https://investors.puretechhealth.com/committee-details/renumeration-committee 2025-12-18T03:07:16-05:00 0.5 https://investors.puretechhealth.com/committee-details/nominating-and-corporate-governance-committee 2025-12-18T03:06:41-05:00 0.5 https://investors.puretechhealth.com/events/event-details/puretech-president-and-chief-business-and-strategy-present-wedbush-pacgrow 2023-08-01T12:17:07-04:00 0.5 https://investors.puretechhealth.com/events/event-details/puretech-ceo-daphne-zohar-present-jefferies-virtual-healthcare-conference 2023-08-01T12:15:43-04:00 0.5 https://investors.puretechhealth.com/events/event-details/puretech-ceo-daphne-zohar-present-19th-annual-virtual-needham-healthcare 2023-08-01T12:10:18-04:00 0.5 https://investors.puretechhealth.com/events/event-details/puretech-ceo-daphne-zohar-present-9th-annual-svb-leerink-global-healthcare 2023-08-01T12:09:28-04:00 0.5 https://investors.puretechhealth.com/events/event-details/puretech-ceo-daphne-zohar-present-29th-annual-credit-suisse-virtual-0 2023-08-01T12:18:54-04:00 0.5 https://investors.puretechhealth.com/events/event-details/puretech-ceo-daphne-zohar-present-jefferies-2020-virtual-london-healthcare 2023-08-01T12:20:13-04:00 0.5 https://investors.puretechhealth.com/events/event-details/puretech-ceo-and-chief-innovation-officer-present-piper-sandler-32nd-annual 2023-08-01T12:23:12-04:00 0.5 https://investors.puretechhealth.com/events/event-details/puretech-ceo-and-chief-innovation-officer-present-evercore-isi-3rd-annual 2023-08-01T12:21:21-04:00 0.5 https://investors.puretechhealth.com/events/event-details/puretech-virtual-rd-day 2023-08-01T12:25:48-04:00 0.5 https://investors.puretechhealth.com/events/event-details/puretech-president-and-chief-business-and-strategy-and-chief-innovation 2021-01-07T16:22:05-05:00 0.5 https://investors.puretechhealth.com/events/event-details/puretech-ceo-present-38th-annual-jp-morgan-healthcare-conference 2021-02-23T18:39:56-05:00 0.5 https://investors.puretechhealth.com/events/event-details/puretech-ceo-present-wuxi-global-forum-2021-advancing-breakthroughs-patients 2023-08-01T12:30:08-04:00 0.5 https://investors.puretechhealth.com/events/event-details/puretech-present-svb-leerink-10th-annual-global-healthcare-conference 2023-08-01T12:32:15-04:00 0.5 https://investors.puretechhealth.com/events/event-details/puretech-present-barclays-global-healthcare-conference 2023-08-01T12:33:15-04:00 0.5 https://investors.puretechhealth.com/events/event-details/puretech-present-2020-annual-report-and-financial-results 2021-04-14T18:26:37-04:00 0.5 https://investors.puretechhealth.com/events/event-details/puretech-present-19th-annual-virtual-needham-healthcare-conference 2023-08-01T12:34:34-04:00 0.5 https://investors.puretechhealth.com/events/event-details/puretech-participates-fireside-chat-liberum 2021-05-11T02:19:55-04:00 0.5 https://investors.puretechhealth.com/events/event-details/puretech-present-jefferies-virtual-healthcare-conference 2024-08-16T11:57:04-04:00 0.5 https://investors.puretechhealth.com/events/event-details/puretech-presents-2021-half-year-results 2021-08-03T11:59:58-04:00 0.5 https://investors.puretechhealth.com/events/event-details/puretech-presents-oppenheimer-fall-healthcare-life-sciences-and-medtech-summit 2024-08-16T11:55:58-04:00 0.5 https://investors.puretechhealth.com/events/event-details/puretech-participate-fireside-chat-jefferies-london-healthcare-conference 2024-08-16T11:55:52-04:00 0.5 https://investors.puretechhealth.com/events/event-details/puretech-participate-fireside-chat-piper-sandler-33rd-annual-virtual 2023-08-01T12:41:58-04:00 0.5 https://investors.puretechhealth.com/events/event-details/puretech-participate-fireside-chat-evercore-isi-4th-annual-healthconx 2023-08-01T12:42:57-04:00 0.5 https://investors.puretechhealth.com/events/event-details/puretech-present-40th-annual-jp-morgan-healthcare-conference 2023-08-01T12:43:51-04:00 0.5 https://investors.puretechhealth.com/events/event-details/puretech-present-svb-leerink-11th-annual-global-healthcare-conference 2023-08-01T12:45:02-04:00 0.5 https://investors.puretechhealth.com/events/event-details/puretech-present-2021-annual-report-and-financial-results 2022-04-27T02:04:18-04:00 0.5 https://investors.puretechhealth.com/events/event-details/puretech-present-ubs-global-healthcare-conference 2022-05-17T07:04:49-04:00 0.5 https://investors.puretechhealth.com/events/event-details/puretech-presents-jefferies-healthcare-conference 2024-08-16T11:55:46-04:00 0.5 https://investors.puretechhealth.com/events/event-details/puretech-present-2022-half-year-results 2022-08-26T14:34:21-04:00 0.5 https://investors.puretechhealth.com/events/event-details/puretech-present-morgan-stanley-global-healthcare-conference 2023-08-01T12:48:05-04:00 0.5 https://investors.puretechhealth.com/events/event-details/puretech-present-credit-suisse-31st-annual-healthcare-conference 2023-08-01T12:49:04-04:00 0.5 https://investors.puretechhealth.com/events/event-details/puretech-present-jefferies-london-healthcare-conference 2023-08-01T12:50:00-04:00 0.5 https://investors.puretechhealth.com/events/event-details/puretech-present-piper-sandler-34th-annual-healthcare-conference 2023-08-01T12:51:01-04:00 0.5 https://investors.puretechhealth.com/events/event-details/puretech-present-evercore-isi-5th-annual-healthconx-conference 2023-08-01T12:51:56-04:00 0.5 https://investors.puretechhealth.com/events/event-details/puretech-present-41st-annual-jp-morgan-healthcare-conference 2023-08-01T12:52:51-04:00 0.5 https://investors.puretechhealth.com/events/event-details/puretech-present-svb-securities-global-biopharma-conference 2023-08-01T12:53:47-04:00 0.5 https://investors.puretechhealth.com/events/event-details/puretech-present-barclays-global-healthcare-conference-0 2023-03-15T10:21:03-04:00 0.5 https://investors.puretechhealth.com/events/event-details/puretech-presents-2022-annual-report-and-financial-results 2023-04-28T08:55:45-04:00 0.5 https://investors.puretechhealth.com/events/event-details/puretech-present-jefferies-healthcare-conference 2023-06-12T16:01:18-04:00 0.5 https://investors.puretechhealth.com/events/event-details/puretech-present-2023-half-year-results 2024-08-16T11:52:29-04:00 0.5 https://investors.puretechhealth.com/events/event-details/puretech-presents-during-jefferies-ceo-back-school-firesides-series 2023-09-22T13:46:31-04:00 0.5 https://investors.puretechhealth.com/events/event-details/puretech-present-jefferies-london-healthcare-conference-0 2024-08-16T11:48:09-04:00 0.5 https://investors.puretechhealth.com/events/event-details/puretech-present-evercore-isi-6th-annual-healthcare-conference 2024-01-11T11:44:22-05:00 0.5 https://investors.puretechhealth.com/events/event-details/puretech-present-42nd-annual-jp-morgan-healthcare-conference 2024-01-11T11:43:27-05:00 0.5 https://investors.puretechhealth.com/events/event-details/puretech-present-td-cowen-44th-annual-health-care-conference 2024-08-16T11:49:50-04:00 0.5 https://investors.puretechhealth.com/events/event-details/puretech-present-leerink-partners-global-biopharma-conference 2024-08-16T11:49:44-04:00 0.5 https://investors.puretechhealth.com/events/event-details/puretech-present-2023-annual-report-and-financial-results 2024-08-16T11:51:54-04:00 0.5 https://investors.puretechhealth.com/events/event-details/puretech-present-jefferies-global-healthcare-conference 2024-08-16T11:49:38-04:00 0.5 https://investors.puretechhealth.com/events/event-details/puretech-presents-2024-half-year-results 2024-08-21T02:04:49-04:00 0.5 https://investors.puretechhealth.com/events/event-details/puretech-present-ubs-global-healthcare-conference-0 2025-01-07T18:25:58-05:00 0.5 https://investors.puretechhealth.com/events/event-details/puretech-present-jefferies-london-healthcare-conference-1 2025-01-07T18:25:05-05:00 0.5 https://investors.puretechhealth.com/events/event-details/elevate-ipf-phase-2b-topline-results 2024-12-16T13:53:49-05:00 0.5 https://investors.puretechhealth.com/events/event-details/puretech-present-43rd-annual-jp-morgan-healthcare-conference 2025-01-16T09:49:21-05:00 0.5 https://investors.puretechhealth.com/events/event-details/puretech-present-leerink-partners-global-healthcare-conference 2025-03-12T09:18:10-04:00 0.5 https://investors.puretechhealth.com/events/event-details/puretech-present-2024-annual-report-and-financial-results 2025-06-17T16:00:23-04:00 0.5 https://investors.puretechhealth.com/events/event-details/puretech-present-jefferies-global-healthcare-conference-0 2025-06-17T11:14:37-04:00 0.5 https://investors.puretechhealth.com/events/event-details/puretech-present-2025-half-year-results 2025-08-28T14:22:08-04:00 0.5 https://investors.puretechhealth.com/events/event-details/puretech-presents-44th-annual-jp-morgan-healthcare-conference 2026-01-15T09:27:21-05:00 0.5 https://investors.puretechhealth.com/events/event-details/puretech-present-leerink-partners-global-healthcare-conference-0 2026-03-17T09:24:36-04:00 0.5 https://investors.puretechhealth.com/investor-relations 2025-08-29T14:59:41-04:00 0.8 https://investors.puretechhealth.com/corporate-profile 2017-12-29T16:39:23-05:00 0.8 https://investors.puretechhealth.com/news/puretech-news 2025-08-12T07:21:26-04:00 0.8 https://investors.puretechhealth.com/events-presentations 2024-11-13T12:47:26-05:00 0.8 https://investors.puretechhealth.com/events-and-presentations/events 2017-12-29T16:39:46-05:00 0.8 https://investors.puretechhealth.com/events-and-presentations/presentations 2020-01-02T09:21:41-05:00 0.8 https://investors.puretechhealth.com/corporate-governance 2020-10-29T12:03:21-04:00 0.8 https://investors.puretechhealth.com/corporate-governance/committee-composition 2020-11-06T15:52:23-05:00 0.8 https://investors.puretechhealth.com/financial-information 2017-12-29T16:39:54-05:00 0.8 https://investors.puretechhealth.com/financials-filings/reports 2025-08-28T12:46:49-04:00 0.8 https://investors.puretechhealth.com/share-information/analyst-coverage 2020-10-30T17:12:32-04:00 0.8 https://investors.puretechhealth.com/share-information 2023-03-30T04:47:12-04:00 0.8 https://investors.puretechhealth.com/share-information/historical-price-lookup 2021-11-09T09:50:06-05:00 0.8 https://investors.puretechhealth.com/share-information/investment-calculator 2020-10-29T11:21:37-04:00 0.8 https://investors.puretechhealth.com/shareholder-services 2017-12-29T16:26:22-05:00 0.8 https://investors.puretechhealth.com/ir-resources/email-alerts 2020-10-29T11:22:53-04:00 0.8 https://investors.puretechhealth.com/rss-feeds 2020-11-01T11:21:17-05:00 0.8 https://investors.puretechhealth.com/shareholder-services/document-request 2017-12-29T16:39:35-05:00 0.8 https://investors.puretechhealth.com/ir-resources/contact-ir 2020-11-06T12:52:55-05:00 0.8 https://investors.puretechhealth.com/financials-filings/sec-filings 2020-10-30T10:15:31-04:00 0.8 https://investors.puretechhealth.com/news 2025-05-01T23:55:05-04:00 0.8 https://investors.puretechhealth.com/news/publications 2023-05-26T14:35:23-04:00 0.8 https://investors.puretechhealth.com/news/latest-science 2020-11-10T07:56:54-05:00 0.8 https://investors.puretechhealth.com/all-news 2025-05-01T23:53:52-04:00 0.8 https://investors.puretechhealth.com/esg 2025-07-09T17:08:26-04:00 0.8 https://investors.puretechhealth.com/news-releases/news-release-details/puretech-founded-entity-vedanta-biosciences-announces-additional 2020-10-14T19:59:08-04:00 0.5 https://investors.puretechhealth.com/news-releases/news-release-details/puretech-founded-entity-akili-announces-presentation-new-outcome 2020-10-21T16:46:54-04:00 0.5 https://investors.puretechhealth.com/news-releases/news-release-details/puretech-founded-entity-vor-biopharma-appoints-matthew-r 2020-10-21T17:08:51-04:00 0.5 https://investors.puretechhealth.com/news-releases/news-release-details/puretech-founded-entity-akili-announces-appointment-chief 2020-10-21T17:10:43-04:00 0.5 https://investors.puretechhealth.com/news-releases/news-release-details/puretech-founded-entity-alivio-therapeutics-awarded-33-million 2021-06-16T07:41:49-04:00 0.5 https://investors.puretechhealth.com/news-releases/news-release-details/puretech-appoints-kiran-mazumdar-shaw-founder-and-chairperson 2021-02-09T02:18:03-05:00 0.5 https://investors.puretechhealth.com/news-releases/news-release-details/puretech-founded-entity-vedanta-biosciences-awarded-769-million 2020-10-21T17:17:44-04:00 0.5 https://investors.puretechhealth.com/news-releases/news-release-details/puretech-founded-entity-alivio-therapeutics-appoints-harry 2021-06-16T07:41:56-04:00 0.5 https://investors.puretechhealth.com/news-releases/news-release-details/puretech-plans-us-listing-nasdaq-global-market 2021-02-05T06:40:06-05:00 0.5 https://investors.puretechhealth.com/news-releases/news-release-details/puretech-founded-entity-vedanta-biosciences-announces 2020-10-22T08:56:36-04:00 0.5 https://investors.puretechhealth.com/news-releases/news-release-details/puretech-founded-entity-gelesis-presents-plenityr-efficacy-and 2020-10-22T09:00:55-04:00 0.5 https://investors.puretechhealth.com/news-releases/news-release-details/puretech-health-2020-half-year-report 2021-02-05T06:41:15-05:00 0.5 https://investors.puretechhealth.com/news-releases/news-release-details/puretech-receives-approximately-100-million-sale-minority 2021-02-05T06:43:55-05:00 0.5 https://investors.puretechhealth.com/news-releases/news-release-details/publication-shareholder-circular-respect-authority-implement 2021-02-05T06:45:30-05:00 0.5 https://investors.puretechhealth.com/news-releases/news-release-details/puretech-founded-entity-vor-biopharma-appoints-john-king-chief 2020-10-22T09:26:20-04:00 0.5 https://investors.puretechhealth.com/news-releases/news-release-details/puretech-founded-entity-sonde-health-acquires-neurolex-labs 2020-10-22T09:27:58-04:00 0.5 https://investors.puretechhealth.com/news-releases/news-release-details/puretech-present-2020-wedbush-pacgrow-healthcare-virtual 2020-10-22T09:45:53-04:00 0.5 https://investors.puretechhealth.com/news-releases/news-release-details/notice-half-yearly-results 2020-10-22T10:10:34-04:00 0.5 https://investors.puretechhealth.com/news-releases/news-release-details/puretech-founded-entity-vor-biopharma-appoints-david-lubner-its 2020-10-22T10:12:21-04:00 0.5 https://investors.puretechhealth.com/news-releases/news-release-details/puretech-founded-entity-vor-biopharma-appoints-daniella-beckman 2020-10-22T10:13:44-04:00 0.5 https://investors.puretechhealth.com/news-releases/news-release-details/puretech-founded-entity-vor-biopharma-appoints-dr-christopher 2020-10-22T10:14:56-04:00 0.5 https://investors.puretechhealth.com/news-releases/news-release-details/puretech-founded-entity-sonde-health-launches-new-voice-enabled 2020-10-22T10:16:21-04:00 0.5 https://investors.puretechhealth.com/news-releases/news-release-details/puretech-founded-entity-vor-biopharma-raises-110-million-series 2020-10-22T10:17:55-04:00 0.5 https://investors.puretechhealth.com/news-releases/news-release-details/puretech-founded-entity-karuna-announces-positive-outcome-end 2020-10-22T10:19:15-04:00 0.5 https://investors.puretechhealth.com/news-releases/news-release-details/puretech-founded-entity-akili-receives-approval-market 2020-10-22T10:20:48-04:00 0.5 https://investors.puretechhealth.com/news-releases/news-release-details/puretech-presents-new-data-reinforcing-galectin-9-compelling 2020-10-22T10:21:55-04:00 0.5 https://investors.puretechhealth.com/news-releases/news-release-details/puretech-founded-entity-gelesis-announces-partnership-commercial 2020-10-22T10:23:29-04:00 0.5 https://investors.puretechhealth.com/news-releases/news-release-details/puretech-founded-entity-akili-announces-fda-clearance 2020-10-22T10:24:50-04:00 0.5 https://investors.puretechhealth.com/news-releases/news-release-details/puretech-founded-entity-vedanta-biosciences-announces-positive 2020-10-22T10:26:45-04:00 0.5 https://investors.puretechhealth.com/news-releases/news-release-details/puretech-founded-entity-follica-announces-positive-feedback-fda 2020-10-22T10:43:24-04:00 0.5 https://investors.puretechhealth.com/news-releases/news-release-details/puretech-founded-entity-gelesis-receives-approval-market 2020-10-22T10:47:07-04:00 0.5 https://investors.puretechhealth.com/news-releases/news-release-details/puretech-advances-lyt-100-deupirfenidone-treatment-serious 2020-10-22T11:01:54-04:00 0.5 https://investors.puretechhealth.com/news-releases/news-release-details/puretech-present-jefferies-virtual-healthcare-conference 2020-11-10T19:31:29-05:00 0.5 https://investors.puretechhealth.com/news-releases/news-release-details/puretech-founded-entity-vor-biopharma-appoints-nathan-jorgensen 2020-10-22T11:04:15-04:00 0.5 https://investors.puretechhealth.com/news-releases/news-release-details/puretech-receives-45-million-sale-minority-portion-founded 2021-02-05T07:22:04-05:00 0.5 https://investors.puretechhealth.com/news-releases/news-release-details/puretech-founded-entity-akili-announces-endeavortm-digital 2020-10-22T11:06:32-04:00 0.5 https://investors.puretechhealth.com/news-releases/news-release-details/puretech-present-19th-annual-virtual-needham-healthcare 2020-11-10T19:33:47-05:00 0.5 https://investors.puretechhealth.com/news-releases/news-release-details/puretech-health-announces-annual-results-year-ended-31-december 2021-02-05T07:23:17-05:00 0.5 https://investors.puretechhealth.com/news-releases/news-release-details/puretech-affiliate-gelesis-named-one-worlds-most-innovative 2020-10-22T11:13:28-04:00 0.5 https://investors.puretechhealth.com/news-releases/news-release-details/notice-results 2020-10-22T11:34:14-04:00 0.5 https://investors.puretechhealth.com/news-releases/news-release-details/puretech-announces-first-participant-dosed-clinical-trial-wholly 2020-10-22T11:40:18-04:00 0.5 https://investors.puretechhealth.com/news-releases/news-release-details/lancet-digital-health-publishes-akili-akl-t01-adhd-pivotal-study 2020-10-22T11:44:27-04:00 0.5 https://investors.puretechhealth.com/news-releases/news-release-details/puretech-present-9th-annual-svb-leerink-global-healthcare 2020-10-22T11:46:00-04:00 0.5 https://investors.puretechhealth.com/news-releases/news-release-details/puretech-receives-200-million-sale-minority-portion-affiliate 2021-02-05T07:27:56-05:00 0.5 https://investors.puretechhealth.com/news-releases/news-release-details/puretech-affiliate-akili-announces-new-akl-t01-study-achieved 2020-10-22T11:53:54-04:00 0.5 https://investors.puretechhealth.com/news-releases/news-release-details/puretech-health-affiliate-follica-announces-positive-topline 2020-10-22T12:12:26-04:00 0.5 https://investors.puretechhealth.com/news-releases/news-release-details/puretech-health-affiliate-gelesis-announces-partnership-ro 2020-10-22T12:16:56-04:00 0.5 https://investors.puretechhealth.com/news-releases/news-release-details/puretech-affiliate-akili-announces-akl-t03-achieved-primary 2020-10-22T12:19:16-04:00 0.5 https://investors.puretechhealth.com/news-releases/news-release-details/puretech-affiliate-vedanta-biosciences-announces-initiation 2020-10-22T12:40:59-04:00 0.5 https://investors.puretechhealth.com/news-releases/news-release-details/puretech-health-affiliate-gelesis-secures-over-84-million-new 2020-10-22T12:47:05-04:00 0.5 https://investors.puretechhealth.com/news-releases/news-release-details/puretech-affiliate-vedanta-biosciences-awarded-58-million-carb-x 2020-10-22T12:55:25-04:00 0.5 https://investors.puretechhealth.com/news-releases/news-release-details/puretech-affiliate-karuna-therapeutics-announces-pricing-250 2020-10-22T12:58:12-04:00 0.5 https://investors.puretechhealth.com/news-releases/news-release-details/puretech-affiliate-karuna-therapeutics-announces-karxt-met 2020-10-22T13:42:46-04:00 0.5 https://investors.puretechhealth.com/news-releases/news-release-details/puretech-present-jefferies-2019-london-healthcare-conference 2020-10-22T13:43:38-04:00 0.5 https://investors.puretechhealth.com/news-releases/news-release-details/puretech-affiliate-gelesis-presents-additional-data-highlighting 2020-10-22T13:45:01-04:00 0.5 https://investors.puretechhealth.com/news-releases/news-release-details/puretech-announces-presentation-new-data-supporting-wholly-owned 2020-10-22T13:46:24-04:00 0.5 https://investors.puretechhealth.com/news-releases/news-release-details/puretech-affiliate-sonde-health-appoints-david-liu-ceo 2020-10-22T13:47:23-04:00 0.5 https://investors.puretechhealth.com/news-releases/news-release-details/acquisition-minority-interests-internal-pipeline-platforms-issue 2020-10-22T13:50:45-04:00 0.5 https://investors.puretechhealth.com/news-releases/news-release-details/puretech-affiliate-vor-biopharma-appoints-senior-cell-and-gene 2020-10-22T13:51:54-04:00 0.5 https://investors.puretechhealth.com/news-releases/news-release-details/puretech-affiliate-vedanta-biosciences-raises-additional-166 2020-10-22T13:53:11-04:00 0.5 https://investors.puretechhealth.com/news-releases/news-release-details/notice-half-yearly-results-0 2020-10-22T14:21:22-04:00 0.5 https://investors.puretechhealth.com/news-releases/news-release-details/puretech-affiliate-vor-biopharma-appoints-robert-ang-mbbs-mba 2020-10-22T14:33:42-04:00 0.5 https://investors.puretechhealth.com/news-releases/news-release-details/puretech-acquires-new-clinical-stage-programme-lyt-100-treat 2020-10-22T14:34:57-04:00 0.5 https://investors.puretechhealth.com/news-releases/news-release-details/potential-us-listing-puretech-health-plc-nasdaq 2020-10-22T14:35:48-04:00 0.5 https://investors.puretechhealth.com/news-releases/news-release-details/puretech-announces-issuance-us-patent-covering-compositions 2020-10-22T14:37:25-04:00 0.5 https://investors.puretechhealth.com/news-releases/news-release-details/puretech-affiliate-karuna-therapeutics-announces-closing-initial 2020-10-22T14:38:44-04:00 0.5 https://investors.puretechhealth.com/news-releases/news-release-details/puretech-health-affiliate-vedanta-biosciences-announces-first 2020-10-22T14:54:53-04:00 0.5 https://investors.puretechhealth.com/news-releases/news-release-details/puretech-affiliate-karuna-announces-pricing-upsized-initial 2020-10-22T14:56:03-04:00 0.5 https://investors.puretechhealth.com/news-releases/news-release-details/puretech-establishes-new-corporate-headquarters-bostons-seaport 2020-11-10T19:35:31-05:00 0.5 https://investors.puretechhealth.com/news-releases/news-release-details/follica-announces-positive-interim-data-and-progression-pivotal 2020-10-22T15:19:46-04:00 0.5 https://investors.puretechhealth.com/news-releases/news-release-details/puretech-health-affiliate-karuna-files-public-registration 2020-10-22T15:21:11-04:00 0.5 https://investors.puretechhealth.com/news-releases/news-release-details/puretech-health-present-jefferies-2019-healthcare-conference 2020-11-10T19:35:57-05:00 0.5 https://investors.puretechhealth.com/news-releases/news-release-details/puretech-health-affiliate-vor-biopharma-publishes-proof-concept 2020-10-22T15:26:24-04:00 0.5 https://investors.puretechhealth.com/news-releases/news-release-details/puretech-health-affiliate-vedanta-biosciences-announces-expanded 2020-10-22T15:27:40-04:00 0.5 https://investors.puretechhealth.com/news-releases/news-release-details/puretech-health-affiliate-gelesis-announces-promising-pilot 2020-10-22T15:28:56-04:00 0.5 https://investors.puretechhealth.com/news-releases/news-release-details/puretech-health-affiliates-gelesis-and-vedanta-biosciences 2021-02-05T07:46:48-05:00 0.5 https://investors.puretechhealth.com/news-releases/news-release-details/puretech-health-affiliate-vedanta-biosciences-closes-extended 2020-10-22T15:32:52-04:00 0.5 https://investors.puretechhealth.com/news-releases/news-release-details/puretechs-vedanta-biosciences-announces-favourable-decision-key 2020-10-22T16:17:27-04:00 0.5 https://investors.puretechhealth.com/news-releases/news-release-details/puretechs-karuna-files-confidential-submission-draft 2020-10-22T16:18:21-04:00 0.5 https://investors.puretechhealth.com/news-releases/news-release-details/puretech-health-affiliate-gelesis-announces-106-eu94-million 2020-10-22T16:20:02-04:00 0.5 https://investors.puretechhealth.com/news-releases/news-release-details/puretech-health-announces-annual-results-year-ended-31-0 2020-11-10T19:36:55-05:00 0.5 https://investors.puretechhealth.com/news-releases/news-release-details/puretech-health-announces-collaboration-boehringer-ingelheim 2020-10-22T16:45:29-04:00 0.5 https://investors.puretechhealth.com/news-releases/news-release-details/puretech-health-affiliate-gelesis-announces-successful-fda 2020-10-22T16:47:41-04:00 0.5 https://investors.puretechhealth.com/news-releases/news-release-details/puretech-health-affiliate-sonde-health-announces-16-million 2020-10-22T16:52:41-04:00 0.5 https://investors.puretechhealth.com/news-releases/news-release-details/puretech-health-affiliate-akili-appoints-chief-financial-officer 2020-10-22T16:53:48-04:00 0.5 https://investors.puretechhealth.com/news-releases/news-release-details/puretech-health-affiliate-gelesis-presents-preclinical-data 2020-10-22T16:55:11-04:00 0.5 https://investors.puretechhealth.com/news-releases/news-release-details/puretech-health-announces-presentation-internal-immuno-oncology 2020-10-22T16:56:33-04:00 0.5 https://investors.puretechhealth.com/news-releases/news-release-details/puretech-health-affiliate-karuna-therapeutics-completes-extended 2020-10-22T16:57:38-04:00 0.5 https://investors.puretechhealth.com/news-releases/news-release-details/puretechs-affiliate-gelesis-presents-data-supporting-lead 2020-10-22T17:12:59-04:00 0.5 https://investors.puretechhealth.com/news-releases/news-release-details/puretech-health-affiliate-gelesis-presents-preclinical-data-0 2020-10-22T17:14:29-04:00 0.5 https://investors.puretechhealth.com/news-releases/news-release-details/puretechs-affiliate-gelesis-announces-three-presentations 2020-10-22T17:15:33-04:00 0.5 https://investors.puretechhealth.com/news-releases/news-release-details/puretechs-affiliate-karuna-announces-68-million-series-b 2020-10-22T17:16:26-04:00 0.5 https://investors.puretechhealth.com/news-releases/news-release-details/puretechs-independent-affiliate-akili-announces-partnership 2020-10-22T17:28:16-04:00 0.5 https://investors.puretechhealth.com/news-releases/news-release-details/puretech-health-affiliate-karuna-announces-appointment-chief 2020-10-22T17:29:18-04:00 0.5 https://investors.puretechhealth.com/news-releases/news-release-details/puretech-announces-first-participant-dosed-clinical-trial-0 2020-10-22T17:36:23-04:00 0.5 https://investors.puretechhealth.com/news-releases/news-release-details/puretech-health-present-two-upcoming-us-investor-conferences 2020-11-10T19:37:26-05:00 0.5 https://investors.puretechhealth.com/news-releases/news-release-details/puretech-health-affiliate-vor-biopharma-announces-42-million 2020-10-22T17:39:28-04:00 0.5 https://investors.puretechhealth.com/news-releases/news-release-details/puretechs-alivio-therapeutics-enters-partnership-purdue-pharma 2022-09-23T10:13:57-04:00 0.5 https://investors.puretechhealth.com/news-releases/news-release-details/puretechs-vedanta-biosciences-publishes-seminal-research-leading 2020-10-22T17:42:02-04:00 0.5 https://investors.puretechhealth.com/news-releases/news-release-details/puretechs-vedanta-biosciences-raises-27-million-financing-round 2020-10-22T17:43:16-04:00 0.5 https://investors.puretechhealth.com/news-releases/news-release-details/puretechs-vedanta-biosciences-announces-initiation-phase-2-study 2020-10-22T17:45:51-04:00 0.5 https://investors.puretechhealth.com/news-releases/news-release-details/bristol-myers-squibb-and-puretechs-vedanta-biosciences-announce 2020-10-22T17:47:21-04:00 0.5 https://investors.puretechhealth.com/news-releases/news-release-details/puretechs-vor-granted-foundational-us-patent-broadly-covering 2020-10-22T17:48:25-04:00 0.5 https://investors.puretechhealth.com/news-releases/news-release-details/puretechs-vedanta-biosciences-announces-initiation-phase-1 2020-10-22T17:49:34-04:00 0.5 https://investors.puretechhealth.com/news-releases/news-release-details/pivotal-weight-loss-data-gelesis100-published-obesity-including 2020-10-22T17:51:12-04:00 0.5 https://investors.puretechhealth.com/news-releases/news-release-details/puretech-health-present-jefferies-2018-london-healthcare 2020-11-10T19:38:03-05:00 0.5 https://investors.puretechhealth.com/news-releases/news-release-details/puretech-healths-vedanta-biosciences-present-preclinical-data 2020-10-22T17:55:22-04:00 0.5 https://investors.puretechhealth.com/news-releases/news-release-details/puretechs-gelesis-present-expanded-pivotal-data-lead-product 2020-10-22T17:56:35-04:00 0.5 https://investors.puretechhealth.com/news-releases/news-release-details/puretechs-karuna-adds-jeff-jonas-md-board-directors 2020-10-22T17:57:30-04:00 0.5 https://investors.puretechhealth.com/news-releases/news-release-details/puretechs-karuna-announces-initiation-phase-2-study-proprietary 2020-10-22T17:58:56-04:00 0.5 https://investors.puretechhealth.com/news-releases/news-release-details/puretechs-vedanta-biosciences-announces-successful-phase-1a1b 2020-10-22T18:00:07-04:00 0.5 https://investors.puretechhealth.com/news-releases/news-release-details/puretech-health-collaborator-publishes-nature-neuroscience 2020-10-22T18:17:26-04:00 0.5 https://investors.puretechhealth.com/news-releases/news-release-details/puretechs-akili-exclusively-licenses-additional-clinical-stage 2020-10-22T18:18:31-04:00 0.5 https://investors.puretechhealth.com/news-releases/news-release-details/puretechs-alivio-awarded-33-million-grant-us-department-defense 2022-09-23T10:14:25-04:00 0.5 https://investors.puretechhealth.com/news-releases/news-release-details/puretechs-vedanta-biosciences-adds-susan-dillon-phd-board 2020-10-22T18:24:57-04:00 0.5 https://investors.puretechhealth.com/news-releases/news-release-details/puretechs-karuna-appoints-steven-paul-md-chief-executive-officer 2020-10-22T18:36:29-04:00 0.5 https://investors.puretechhealth.com/news-releases/news-release-details/puretechs-akili-expands-series-c-funding-increasing-round-68 2020-10-22T18:37:39-04:00 0.5 https://investors.puretechhealth.com/news-releases/news-release-details/puretechs-karuna-completes-42-million-financing-round-advance 2020-10-22T18:43:19-04:00 0.5 https://investors.puretechhealth.com/news-releases/news-release-details/puretech-health-collaborator-publishes-journal-nature-regarding 2020-10-22T18:58:24-04:00 0.5 https://investors.puretechhealth.com/news-releases/news-release-details/puretech-health-announces-collaboration-roche-advance-technology 2020-10-22T18:59:30-04:00 0.5 https://investors.puretechhealth.com/news-releases/news-release-details/puretechs-vedanta-biosciences-receives-award-crohns-colitis 2020-10-22T19:00:21-04:00 0.5 https://investors.puretechhealth.com/news-releases/news-release-details/puretechs-karuna-receives-8-million-wellcome-trust-award-advance 2020-10-22T19:01:32-04:00 0.5 https://investors.puretechhealth.com/news-releases/news-release-details/puretechs-gelesis-appoints-harry-leider-former-walgreens-chief 2020-10-22T19:02:48-04:00 0.5 https://investors.puretechhealth.com/news-releases/news-release-details/puretech-health-present-jefferies-2018-global-healthcare 2020-11-10T20:09:31-05:00 0.5 https://investors.puretechhealth.com/news-releases/news-release-details/puretechs-alivio-granted-two-us-patents-broadly-covering 2022-09-23T10:18:03-04:00 0.5 https://investors.puretechhealth.com/news-releases/news-release-details/results-annual-general-meeting 2020-10-23T11:13:36-04:00 0.5 https://investors.puretechhealth.com/news-releases/news-release-details/puretechs-akili-raises-55-million-advance-digital-medicine 2020-10-23T11:22:53-04:00 0.5 https://investors.puretechhealth.com/news-releases/news-release-details/puretech-health-affiliate-sonde-adds-thai-lee-board-directors 2020-10-23T11:44:20-04:00 0.5 https://investors.puretechhealth.com/news-releases/news-release-details/puretech-health-appoints-joep-muijrers-chief-financial-officer 2020-10-23T12:00:42-04:00 0.5 https://investors.puretechhealth.com/news-releases/news-release-details/puretech-health-announces-annual-results-year-ended-31-1 2020-10-23T12:01:57-04:00 0.5 https://investors.puretechhealth.com/news-releases/news-release-details/puretech-health-affiliates-expand-digital-medicine-ip-portfolios 2020-10-23T12:03:11-04:00 0.5 https://investors.puretechhealth.com/news-releases/news-release-details/puretechs-alivio-technology-published-nature-communications 2022-09-23T10:19:35-04:00 0.5 https://investors.puretechhealth.com/news-releases/news-release-details/results-general-meeting 2020-10-23T12:55:11-04:00 0.5 https://investors.puretechhealth.com/news-releases/news-release-details/publication-circular-and-notice-general-meeting 2020-10-23T12:56:34-04:00 0.5 https://investors.puretechhealth.com/news-releases/news-release-details/results-placing 2020-10-23T13:07:43-04:00 0.5 https://investors.puretechhealth.com/news-releases/news-release-details/proposed-placing-and-notice-general-meeting 2020-10-23T13:10:22-04:00 0.5 https://investors.puretechhealth.com/news-releases/news-release-details/puretechs-gelesis-raises-30-million-prepare-potential-launch 2020-10-23T13:11:37-04:00 0.5 https://investors.puretechhealth.com/news-releases/news-release-details/puretechs-entrega-receive-5-million-investment-lilly-advance 2020-10-23T13:12:33-04:00 0.5 https://investors.puretechhealth.com/news-releases/news-release-details/puretechs-vedanta-biosciences-granted-four-new-us-patents 2020-10-23T13:19:26-04:00 0.5 https://investors.puretechhealth.com/news-releases/news-release-details/puretechs-microbiome-programme-advances-phase-1a1b-clinical 2020-10-23T13:44:03-04:00 0.5 https://investors.puretechhealth.com/news-releases/news-release-details/puretechs-akili-achieves-primary-endpoint-pivotal-study 2020-10-26T15:30:45-04:00 0.5 https://investors.puretechhealth.com/news-releases/news-release-details/puretechs-vedanta-biosciences-expands-clinical-translational 2020-10-26T15:31:51-04:00 0.5 https://investors.puretechhealth.com/news-releases/news-release-details/puretech-health-present-piper-jaffray-2017-healthcare-conference 2020-10-26T15:33:44-04:00 0.5 https://investors.puretechhealth.com/news-releases/news-release-details/puretech-health-present-jefferies-2017-healthcare-conference 2020-10-26T15:34:45-04:00 0.5 https://investors.puretechhealth.com/news-releases/news-release-details/puretechs-vedanta-biosciences-awarded-54-million-grant-combating 2020-10-26T15:36:08-04:00 0.5 https://investors.puretechhealth.com/news-releases/news-release-details/puretech-healths-vedanta-licenses-microbiome-derived-immuno 2020-10-26T15:37:57-04:00 0.5 https://investors.puretechhealth.com/news-releases/news-release-details/puretech-healths-gelesis-reports-significant-weight-loss 2020-10-26T15:39:17-04:00 0.5 https://investors.puretechhealth.com/news-releases/news-release-details/puretech-health-notes-us-patent-issuance-broadly-covering 2020-10-26T15:40:16-04:00 0.5 https://investors.puretechhealth.com/news-releases/news-release-details/puretech-health-exclusively-licenses-novel-milk-derived-exosome 2020-10-26T15:41:13-04:00 0.5 https://investors.puretechhealth.com/news-releases/news-release-details/puretech-health-exclusively-licenses-glyph-technology-monash 2020-10-26T15:42:30-04:00 0.5 https://investors.puretechhealth.com/news-releases/news-release-details/puretech-health-notice-half-yearly-results 2020-10-26T15:44:52-04:00 0.5 https://investors.puretechhealth.com/news-releases/news-release-details/puretech-health-presents-data-supporting-treatment-approach 2022-09-23T10:12:13-04:00 0.5 https://investors.puretechhealth.com/news-releases/news-release-details/puretech-healths-gelesis-announces-last-patient-visit-pivotal 2020-10-26T16:17:00-04:00 0.5 https://investors.puretechhealth.com/news-releases/news-release-details/puretech-healths-akili-appoints-former-cubist-ceo-rob-perez 2020-10-26T16:59:45-04:00 0.5 https://investors.puretechhealth.com/news-releases/news-release-details/puretech-healths-vedanta-biosciences-granted-us-patent-broadly 2020-10-26T17:01:18-04:00 0.5 https://investors.puretechhealth.com/news-releases/news-release-details/puretech-health-present-jefferies-2017-global-healthcare 2020-10-26T17:02:30-04:00 0.5 https://investors.puretechhealth.com/news-releases/news-release-details/puretech-healths-karuna-present-tolerability-proof-concept-data 2020-10-26T17:03:44-04:00 0.5 https://investors.puretechhealth.com/news-releases/news-release-details/puretech-healths-vedanta-biosciences-granted-three-new-us 2020-10-26T17:05:10-04:00 0.5 https://investors.puretechhealth.com/news-releases/news-release-details/2017-results-annual-general-meeting 2020-10-26T17:13:50-04:00 0.5 https://investors.puretechhealth.com/news-releases/news-release-details/puretech-health-announces-initiation-phase-2b-mtorc1-inhibitors 2020-10-26T17:16:20-04:00 0.5 https://investors.puretechhealth.com/news-releases/news-release-details/gelesis-announces-eu29-million-award-italian-ministry-economic 2020-10-26T17:18:36-04:00 0.5 https://investors.puretechhealth.com/news-releases/news-release-details/puretech-health-advances-new-programme-targeting 2020-10-26T17:24:56-04:00 0.5 https://investors.puretechhealth.com/news-releases/news-release-details/puretech-healths-akili-announces-results-project-evotm-pilot 2020-10-26T17:26:31-04:00 0.5 https://investors.puretechhealth.com/news-releases/news-release-details/puretech-health-announces-annual-results-year-ended-31-2 2020-10-26T17:28:24-04:00 0.5 https://investors.puretechhealth.com/news-releases/news-release-details/puretech-health-announces-licensing-and-equity-agreement 2020-10-26T17:36:06-04:00 0.5 https://investors.puretechhealth.com/news-releases/news-release-details/notice-results-fye-2016 2020-10-26T17:37:21-04:00 0.5 https://investors.puretechhealth.com/news-releases/news-release-details/puretech-health-appoints-bharatt-chowrira-phd-jd-president-and 2020-10-27T11:38:57-04:00 0.5 https://investors.puretechhealth.com/news-releases/news-release-details/puretech-health-annual-capital-markets-meeting-london 2020-10-27T11:37:49-04:00 0.5 https://investors.puretechhealth.com/news-releases/news-release-details/puretech-health-present-cowen-and-company-37th-annual-health 2020-10-27T11:40:01-04:00 0.5 https://investors.puretechhealth.com/news-releases/news-release-details/puretech-health-appoints-atul-pande-md-former-svp 2020-10-27T11:41:01-04:00 0.5 https://investors.puretechhealth.com/news-releases/news-release-details/puretech-healths-vedanta-biosciences-announces-clinical 2020-10-27T11:42:00-04:00 0.5 https://investors.puretechhealth.com/news-releases/news-release-details/puretech-health-present-leerink-partners-6th-annual-global 2020-10-27T11:43:26-04:00 0.5 https://investors.puretechhealth.com/news-releases/news-release-details/karuna-pharmaceuticals-and-puretech-health-announce-positive 2020-10-27T11:56:27-04:00 0.5 https://investors.puretechhealth.com/news-releases/news-release-details/puretech-healths-akili-and-pfizer-present-positive-data-digital 2020-10-27T11:58:58-04:00 0.5 https://investors.puretechhealth.com/news-releases/news-release-details/administration-gelesis200-increases-fullness-and-satiety-people 2020-10-27T11:59:59-04:00 0.5 https://investors.puretechhealth.com/news-releases/news-release-details/puretech-health-present-jefferies-2016-healthcare-conference 2020-10-27T12:01:05-04:00 0.5 https://investors.puretechhealth.com/news-releases/news-release-details/puretech-health-appoints-industry-leader-joseph-bolen-chief 2020-10-27T13:39:09-04:00 0.5 https://investors.puretechhealth.com/news-releases/news-release-details/vedanta-biosciences-granted-first-european-patent-broadly 2020-10-27T13:40:15-04:00 0.5 https://investors.puretechhealth.com/news-releases/news-release-details/karuna-doses-first-subject-tolerability-proof-concept-study-lead 2020-10-27T13:41:26-04:00 0.5 https://investors.puretechhealth.com/news-releases/news-release-details/vedanta-biosciences-granted-third-us-patent-covering-methods 2020-10-27T13:55:36-04:00 0.5 https://investors.puretechhealth.com/news-releases/news-release-details/gelesis-appoints-new-chief-operating-officer 2020-10-27T13:56:38-04:00 0.5 https://investors.puretechhealth.com/news-releases/news-release-details/vedanta-biosciences-granted-second-us-patent-covering-methods 2020-10-27T14:09:06-04:00 0.5 https://investors.puretechhealth.com/news-releases/news-release-details/vedanta-biosciences-granted-us-patent-broadly-covering 2020-10-27T14:26:51-04:00 0.5 https://investors.puretechhealth.com/news-releases/news-release-details/vedanta-biosciences-announces-collaboration-nyu-langone-medical 2020-10-27T14:29:16-04:00 0.5 https://investors.puretechhealth.com/news-releases/news-release-details/karuna-pharmaceuticals-appoints-atul-pande-md-board-directors 2020-10-27T14:32:33-04:00 0.5 https://investors.puretechhealth.com/news-releases/news-release-details/akili-adds-amgen-ventures-and-m-ventures-series-b-financing 2020-10-27T14:47:24-04:00 0.5 https://investors.puretechhealth.com/news-releases/news-release-details/puretech-health-appoints-feng-zhang-scientific-advisory-board 2020-10-27T14:48:58-04:00 0.5 https://investors.puretechhealth.com/news-releases/news-release-details/sonde-health-advances-novel-vocal-biomarker-analysis-platform 2020-10-27T14:50:35-04:00 0.5 https://investors.puretechhealth.com/news-releases/news-release-details/ey-names-puretech-healths-co-founder-and-chief-executive-officer 2020-10-27T15:06:27-04:00 0.5 https://investors.puretechhealth.com/news-releases/news-release-details/vedanta-biosciences-closes-50-million-financing-advance 2020-10-27T15:07:45-04:00 0.5 https://investors.puretechhealth.com/news-releases/news-release-details/digital-medicine-company-akili-interactive-labs-raises-305 2020-10-27T15:08:32-04:00 0.5 https://investors.puretechhealth.com/news-releases/news-release-details/puretech-health-present-jefferies-2016-healthcare-conference-new 2020-10-27T15:26:02-04:00 0.5 https://investors.puretechhealth.com/news-releases/news-release-details/results-annual-general-meeting-0 2020-10-27T15:27:16-04:00 0.5 https://investors.puretechhealth.com/news-releases/news-release-details/results-annual-general-meeting-1 2020-10-27T16:45:24-04:00 0.5 https://investors.puretechhealth.com/news-releases/news-release-details/puretech-health-teams-siddhartha-mukherjee-launch-vor-biopharma 2020-10-27T16:47:26-04:00 0.5 https://investors.puretechhealth.com/news-releases/news-release-details/akili-interactive-labs-opens-enrollment-pivotal-trial-novel-adhd 2020-10-27T16:49:02-04:00 0.5 https://investors.puretechhealth.com/news-releases/news-release-details/puretech-health-launches-alivio-therapeutics-and-advances-novel 2022-09-23T10:21:43-04:00 0.5 https://investors.puretechhealth.com/news-releases/news-release-details/gelesis-announces-positive-safety-data-first-human-study-second 2020-10-27T16:52:40-04:00 0.5 https://investors.puretechhealth.com/news-releases/news-release-details/gelesis-announces-first-us-patient-enrolled-pivotal-gelesis100 2020-10-27T16:54:13-04:00 0.5 https://investors.puretechhealth.com/news-releases/news-release-details/vedanta-biosciences-announces-license-agreement-riken-and-other 2020-10-27T16:55:43-04:00 0.5 https://investors.puretechhealth.com/news-releases/news-release-details/vedanta-biosciences-appoints-new-chief-scientific-officer-and 2020-10-27T16:57:36-04:00 0.5 https://investors.puretechhealth.com/news-releases/news-release-details/puretech-health-expands-scientific-advisory-board-and-appoints 2020-10-27T17:00:47-04:00 0.5 https://investors.puretechhealth.com/news-releases/news-release-details/operating-company-gelesis-closes-315-million-growth-financing 2020-10-27T17:02:04-04:00 0.5 https://investors.puretechhealth.com/news-releases/news-release-details/puretech-health-names-scientific-advisory-board-and-expands 2020-10-27T17:05:31-04:00 0.5 https://investors.puretechhealth.com/news-releases/news-release-details/pilot-study-results-demonstrate-akilis-mobile-digital 2020-10-27T17:06:48-04:00 0.5 https://investors.puretechhealth.com/news-releases/news-release-details/vedanta-biosciences-expands-team-additions-head-preclinical 2020-10-27T17:07:51-04:00 0.5 https://investors.puretechhealth.com/news-releases/news-release-details/follica-announces-allowance-us-patent-related-its-principal 2020-10-27T17:13:08-04:00 0.5 https://investors.puretechhealth.com/news-releases/news-release-details/karuna-receives-wellcome-trust-award-advance-innovative-clinical 2020-10-27T17:14:40-04:00 0.5 https://investors.puretechhealth.com/news-releases/news-release-details/gelesis-announces-initiation-six-month-weight-loss-study 2020-10-27T17:16:51-04:00 0.5 https://investors.puretechhealth.com/news-releases/news-release-details/puretech-files-publicly-nasdaq-listing 2021-03-23T06:40:51-04:00 0.5 https://investors.puretechhealth.com/news-releases/news-release-details/gelesis-expands-team-advance-further-clinical-development-its 2020-10-28T14:42:24-04:00 0.5 https://investors.puretechhealth.com/news-releases/news-release-details/enlight-biosciences-forms-new-partnerships-astrazeneca-and-novo 2020-10-28T14:43:25-04:00 0.5 https://investors.puretechhealth.com/news-releases/news-release-details/new-oral-biologics-delivery-company-entrega-announces 2020-10-28T15:06:24-04:00 0.5 https://investors.puretechhealth.com/news-releases/news-release-details/puretech-present-2020-wedbush-pacgrow-healthcare-virtual-0 2021-02-05T06:47:00-05:00 0.5 https://investors.puretechhealth.com/news-releases/news-release-details/notice-half-yearly-results-1 2021-02-05T06:49:28-05:00 0.5 https://investors.puretechhealth.com/news-releases/news-release-details/puretech-presents-new-data-reinforcing-galectin-9-compelling-0 2022-09-23T10:01:53-04:00 0.5 https://investors.puretechhealth.com/news-releases/news-release-details/puretech-advances-lyt-100-deupirfenidone-treatment-serious-0 2022-09-23T09:52:53-04:00 0.5 https://investors.puretechhealth.com/news-releases/news-release-details/puretech-announces-first-participant-dosed-clinical-trial-1 2022-09-23T09:57:03-04:00 0.5 https://investors.puretechhealth.com/news-releases/news-release-details/puretech-present-jefferies-2019-london-healthcare-conference-0 2021-02-05T07:29:21-05:00 0.5 https://investors.puretechhealth.com/news-releases/news-release-details/puretech-announces-presentation-new-data-supporting-wholly-0 2024-04-03T17:28:26-04:00 0.5 https://investors.puretechhealth.com/news-releases/news-release-details/acquisition-minority-interests-internal-pipeline-platforms-0 2020-10-28T15:55:06-04:00 0.5 https://investors.puretechhealth.com/news-releases/news-release-details/puretech-announces-board-change-0 2021-02-05T07:31:00-05:00 0.5 https://investors.puretechhealth.com/news-releases/news-release-details/notice-half-yearly-results-2 2021-02-05T06:49:41-05:00 0.5 https://investors.puretechhealth.com/news-releases/news-release-details/puretech-acquires-new-clinical-stage-programme-lyt-100-treat-0 2022-09-23T09:56:06-04:00 0.5 https://investors.puretechhealth.com/news-releases/news-release-details/potential-us-listing-puretech-health-plc-nasdaq-0 2021-02-05T07:35:39-05:00 0.5 https://investors.puretechhealth.com/news-releases/news-release-details/puretech-announces-issuance-us-patent-covering-compositions-0 2022-09-23T10:02:24-04:00 0.5 https://investors.puretechhealth.com/news-releases/news-release-details/puretech-health-announces-collaboration-boehringer-ingelheim-0 2022-09-23T10:16:37-04:00 0.5 https://investors.puretechhealth.com/news-releases/news-release-details/puretech-health-announces-presentation-internal-immuno-0 2022-09-23T09:58:28-04:00 0.5 https://investors.puretechhealth.com/news-releases/news-release-details/puretech-announces-first-participant-dosed-clinical-trial-2 2022-09-23T09:53:49-04:00 0.5 https://investors.puretechhealth.com/news-releases/news-release-details/puretech-health-collaborator-publishes-nature-neuroscience-0 2022-09-23T10:17:08-04:00 0.5 https://investors.puretechhealth.com/news-releases/news-release-details/puretech-health-collaborator-publishes-journal-nature-0 2022-09-23T10:20:02-04:00 0.5 https://investors.puretechhealth.com/news-releases/news-release-details/puretech-health-announces-collaboration-roche-advance-0 2022-09-23T10:17:37-04:00 0.5 https://investors.puretechhealth.com/news-releases/news-release-details/puretech-health-exclusively-licenses-novel-milk-derived-0 2022-09-23T10:20:29-04:00 0.5 https://investors.puretechhealth.com/news-releases/news-release-details/puretech-health-exclusively-licenses-glyph-technology-monash-0 2022-09-23T10:21:13-04:00 0.5 https://investors.puretechhealth.com/news-releases/news-release-details/puretech-health-advances-new-programme-targeting-0 2022-09-23T09:59:52-04:00 0.5 https://investors.puretechhealth.com/news-releases/news-release-details/frontiers-progress-toward-identifying-exact-proxies-predicting 2020-10-29T10:24:56-04:00 0.5 https://investors.puretechhealth.com/news-releases/news-release-details/lancet-digital-health-novel-digital-intervention-actively 2020-11-02T08:59:11-05:00 0.5 https://investors.puretechhealth.com/news-releases/news-release-details/pnas-gene-edited-stem-cells-enable-cd33-directed-immune-therapy 2020-11-02T09:00:05-05:00 0.5 https://investors.puretechhealth.com/news-releases/news-release-details/nature-defined-commensal-consortium-elicits-cd8-t-cells-and-anti 2020-11-02T09:01:12-05:00 0.5 https://investors.puretechhealth.com/news-releases/news-release-details/nature-neuroscience-cns-lymphatic-drainage-and-neuroinflammation 2021-02-03T11:12:54-05:00 0.5 https://investors.puretechhealth.com/news-releases/news-release-details/nature-functional-aspects-meningeal-lymphatics-ageing-and 2020-11-02T09:06:46-05:00 0.5 https://investors.puretechhealth.com/news-releases/news-release-details/nature-communications-towards-arthritis-flare-responsive-drug 2021-06-16T07:42:31-04:00 0.5 https://investors.puretechhealth.com/news-releases/news-release-details/cell-regulatory-t-cells-skin-facilitate-epithelial-stem-cell 2020-11-02T09:10:21-05:00 0.5 https://investors.puretechhealth.com/news-releases/news-release-details/nature-video-game-training-enhances-cognitive-control-older 2020-11-02T09:11:01-05:00 0.5 https://investors.puretechhealth.com/news-releases/news-release-details/depression-and-anxiety-improving-late-life-depression-and 2020-11-02T09:11:35-05:00 0.5 https://investors.puretechhealth.com/news-releases/news-release-details/nature-medicine-dectin-1-activation-macrophages-galectin-9 2020-11-02T09:12:18-05:00 0.5 https://investors.puretechhealth.com/news-releases/news-release-details/plos-one-pilot-study-determine-feasibility-enhancing-cognitive 2020-11-02T09:12:50-05:00 0.5 https://investors.puretechhealth.com/news-releases/news-release-details/angewandte-chemie-glyceride-mimetic-prodrugs-incorporating-self 2020-11-02T09:13:25-05:00 0.5 https://investors.puretechhealth.com/news-releases/news-release-details/angewandte-chemie-glyceride-mimetic-prodrugs-incorporating-0 2020-11-02T09:31:46-05:00 0.5 https://investors.puretechhealth.com/news-releases/news-release-details/translational-psychiatry-characterizing-cognitive-control 2020-11-02T09:32:53-05:00 0.5 https://investors.puretechhealth.com/news-releases/news-release-details/cell-gd-t-cells-support-pancreatic-oncogenesis-restraining-ab-t 2020-11-02T09:33:36-05:00 0.5 https://investors.puretechhealth.com/news-releases/news-release-details/nature-immunology-gut-microbiome-derived-metabolites-modulate 2020-11-02T09:34:16-05:00 0.5 https://investors.puretechhealth.com/news-releases/news-release-details/bovine-milk-derived-exosomes-drug-delivery 2020-11-02T09:35:06-05:00 0.5 https://investors.puretechhealth.com/news-releases/news-release-details/nature-reviews-drug-discovery-sewer-saviour-targeting-lymphatic 2020-11-02T09:35:40-05:00 0.5 https://investors.puretechhealth.com/news-releases/news-release-details/cell-th17-cell-induction-adhesion-microbes-intestinal-epithelial 2020-11-02T09:36:24-05:00 0.5 https://investors.puretechhealth.com/news-releases/news-release-details/proceedings-interspeech-segment-dependent-dynamics-predicting 2020-11-02T09:36:56-05:00 0.5 https://investors.puretechhealth.com/news-releases/news-release-details/proceedings-4th-international-workshop-audiovisual-emotion 2020-11-02T09:39:08-05:00 0.5 https://investors.puretechhealth.com/news-releases/news-release-details/journal-controlled-release-targeted-delivery-model 2020-11-02T09:39:44-05:00 0.5 https://investors.puretechhealth.com/news-releases/news-release-details/nature-treg-induction-rationally-selected-mixture-clostridia 2020-11-02T09:56:18-05:00 0.5 https://investors.puretechhealth.com/news-releases/news-release-details/nature-fgf9-dermal-gd-t-cells-induces-hair-follicle-neogenesis 2020-11-02T10:00:47-05:00 0.5 https://investors.puretechhealth.com/news-releases/news-release-details/nature-commensal-microbe-derived-butyrate-induces 2020-11-02T10:03:01-05:00 0.5 https://investors.puretechhealth.com/news-releases/news-release-details/nature-biotechnology-medicines-microbiota 2020-11-02T10:03:47-05:00 0.5 https://investors.puretechhealth.com/news-releases/news-release-details/science-induction-colonic-regulatory-t-cells-indigenous 2020-11-02T10:05:38-05:00 0.5 https://investors.puretechhealth.com/news-releases/news-release-details/nature-wnt-dependent-de-novo-hair-follicle-regeneration-adult 2020-11-02T10:47:46-05:00 0.5 https://investors.puretechhealth.com/news-releases/news-release-details/arch-neurol-effects-xanomeline-selective-muscarinic-receptor 2020-11-02T10:48:19-05:00 0.5 https://investors.puretechhealth.com/news-releases/news-release-details/gelesis-presents-new-data-obesityweek 2020-11-06T13:20:31-05:00 0.5 https://investors.puretechhealth.com/news-releases/news-release-details/puretech-presents-credit-suisse-conference 2020-11-10T16:40:41-05:00 0.5 https://investors.puretechhealth.com/news-releases/news-release-details/puretech-present-9th-annual-svb-leerink-global-healthcare-0 2020-11-10T10:40:20-05:00 0.5 https://investors.puretechhealth.com/news-releases/news-release-details/publication-shareholder-circular 2021-02-05T06:42:41-05:00 0.5 https://investors.puretechhealth.com/news-releases/news-release-details/result-agm 2021-02-05T07:37:35-05:00 0.5 https://investors.puretechhealth.com/news-releases/news-release-details/notice-results-1 2021-02-05T07:26:20-05:00 0.5 https://investors.puretechhealth.com/news-releases/news-release-details/vor-licenses-clinical-stage-cd33-car-t-therapy 2020-11-11T16:17:11-05:00 0.5 https://investors.puretechhealth.com/news-releases/news-release-details/sonde-respiratory-portal-available-developers 2021-03-23T06:13:53-04:00 0.5 https://investors.puretechhealth.com/news-releases/news-release-details/btg 2021-02-05T07:33:04-05:00 0.5 https://investors.puretechhealth.com/news-releases/news-release-details/result-agm-0 2021-02-05T07:37:47-05:00 0.5 https://investors.puretechhealth.com/news-releases/news-release-details/final-results-0 2021-02-05T07:49:39-05:00 0.5 https://investors.puretechhealth.com/news-releases/news-release-details/notice-results-3 2021-02-05T07:26:39-05:00 0.5 https://investors.puretechhealth.com/news-releases/news-release-details/puretech-commence-trading-nasdaq-november-16-2020 2020-11-13T12:21:42-05:00 0.5 https://investors.puretechhealth.com/news-releases/news-release-details/gelesis-presents-new-data-liver-meeting 2021-03-23T06:14:21-04:00 0.5 https://investors.puretechhealth.com/news-releases/news-release-details/guidance-exchanging-ordinary-shares-adss 2021-03-23T06:14:59-04:00 0.5 https://investors.puretechhealth.com/news-releases/news-release-details/puretech-present-three-investor-conferences 2021-03-23T06:42:30-04:00 0.5 https://investors.puretechhealth.com/news-releases/news-release-details/puretechs-lyt-100-deupirfenidone-demonstrates-tolerability-and 2022-09-23T09:51:56-04:00 0.5 https://investors.puretechhealth.com/news-releases/news-release-details/vedanta-appoints-karuna-cfo-troy-ignelzi-bod 2021-03-23T06:15:28-04:00 0.5 https://investors.puretechhealth.com/news-releases/news-release-details/puretech-host-virtual-rd-day-investors 2021-03-23T06:15:54-04:00 0.5 https://investors.puretechhealth.com/news-releases/news-release-details/puretech-initiates-phase-2-trial-lyt-100-deupirfenidone-long 2022-09-23T09:51:21-04:00 0.5 https://investors.puretechhealth.com/news-releases/news-release-details/follica-female-hair-loss-academic-study-published 2021-03-23T06:02:54-04:00 0.5 https://investors.puretechhealth.com/news-releases/news-release-details/puretech-initiates-phase-2a-trial-lyt-100-deupirfenidone 2022-09-23T09:48:06-04:00 0.5 https://investors.puretechhealth.com/news-releases/news-release-details/puretech-advances-wholly-owned-candidate-lyt-200-phase-1-trial 2024-04-03T17:30:06-04:00 0.5 https://investors.puretechhealth.com/news-releases/news-release-details/puretech-present-38th-annual-jp-morgan-healthcare-conference-and 2020-12-21T08:58:15-05:00 0.5 https://investors.puretechhealth.com/news-releases/news-release-details/puretech-announces-appointment-george-farmer-phd-chief-financial 2021-03-23T05:58:06-04:00 0.5 https://investors.puretechhealth.com/news-releases/news-release-details/puretech-founded-entity-vedanta-biosciences-announces-25-million 2021-03-23T05:57:19-04:00 0.5 https://investors.puretechhealth.com/news-releases/news-release-details/puretech-founded-entity-follica-adds-two-leaders-aesthetic 2021-03-23T05:51:56-04:00 0.5 https://investors.puretechhealth.com/news-releases/news-release-details/puretech-founded-entity-vor-announces-fda-clearance-ind 2021-03-23T05:51:27-04:00 0.5 https://investors.puretechhealth.com/news-releases/news-release-details/vor-files-ipo-registration-statement-nasdaq 2021-03-23T05:50:56-04:00 0.5 https://investors.puretechhealth.com/news-releases/news-release-details/puretech-adds-bharatt-chowrira-puretechs-president-and-chief 2021-03-23T05:49:48-04:00 0.5 https://investors.puretechhealth.com/news-releases/news-release-details/puretech-founded-entity-vor-biopharma-announces-pricing-initial 2021-03-23T05:49:11-04:00 0.5 https://investors.puretechhealth.com/news-releases/news-release-details/puretech-founded-entity-vedanta-biosciences-appoints-mark 2021-03-23T05:48:26-04:00 0.5 https://investors.puretechhealth.com/news-releases/news-release-details/puretech-receives-approximately-118-million-sale-portion-founded 2021-03-23T04:26:17-04:00 0.5 https://investors.puretechhealth.com/news-releases/news-release-details/puretech-founded-entity-vor-biopharma-closes-over-200m-initial 2021-03-23T05:47:46-04:00 0.5 https://investors.puretechhealth.com/news-releases/news-release-details/puretech-present-svb-leerink-10th-annual-global-healthcare 2021-03-23T05:47:14-04:00 0.5 https://investors.puretechhealth.com/news-releases/news-release-details/puretech-founded-entity-karuna-therapeutics-announces-new 2021-03-23T05:46:44-04:00 0.5 https://investors.puretechhealth.com/news-releases/news-release-details/puretech-announces-publication-glyphtm-platform-preclinical 2022-09-23T10:16:07-04:00 0.5 https://investors.puretechhealth.com/news-releases/news-release-details/puretech-founded-entity-karuna-therapeutics-announces-pricing 2021-03-23T04:24:38-04:00 0.5 https://investors.puretechhealth.com/news-releases/news-release-details/puretech-present-barclays-global-healthcare-conference 2021-03-23T04:29:46-04:00 0.5 https://investors.puretechhealth.com/news-releases/news-release-details/notice-results-4 2021-03-23T04:27:45-04:00 0.5 https://investors.puretechhealth.com/news-releases/news-release-details/puretech-announces-board-member-retirement 2021-03-23T04:27:16-04:00 0.5 https://investors.puretechhealth.com/news-releases/news-release-details/journal-controlled-release-targeted-delivery-mycophenolic-acid 2021-03-26T10:40:37-04:00 0.5 https://investors.puretechhealth.com/news-releases/news-release-details/puretech-founded-entity-akili-announces-results-endeavorrxtm 2021-03-26T08:39:51-04:00 0.5 https://investors.puretechhealth.com/news-releases/news-release-details/nature-digital-medicine-effectiveness-digital-therapeutic 2021-03-26T11:14:17-04:00 0.5 https://investors.puretechhealth.com/news-releases/news-release-details/new-england-journal-medicine-muscarinic-cholinergic-receptor 2021-03-26T11:14:11-04:00 0.5 https://investors.puretechhealth.com/news-releases/news-release-details/international-journal-womens-dermatology-pilot-evaluation-scalp 2021-03-26T11:14:05-04:00 0.5 https://investors.puretechhealth.com/news-releases/news-release-details/akili-collab-study-long-covid-related-brain-fog 2021-04-07T05:51:59-04:00 0.5 https://investors.puretechhealth.com/news-releases/news-release-details/puretech-present-two-upcoming-investor-conferences 2021-04-07T07:04:20-04:00 0.5 https://investors.puretechhealth.com/news-releases/news-release-details/puretech-presents-promising-preclinical-data-lyt-210-immuno 2022-09-23T10:07:40-04:00 0.5 https://investors.puretechhealth.com/news-releases/news-release-details/puretech-announces-annual-results-year-ended-december-31-2020 2021-04-15T03:55:53-04:00 0.5 https://investors.puretechhealth.com/news-releases/news-release-details/puretech-founded-entity-gelesis-appoints-procter-gamble-veteran 2021-04-26T08:08:24-04:00 0.5 https://investors.puretechhealth.com/news-releases/news-release-details/puretech-announces-nature-publication-supporting-modulation 2021-04-28T11:20:27-04:00 0.5 https://investors.puretechhealth.com/news-releases/news-release-details/nature-meningeal-lymphatics-affect-microglia-responses-and-anti 2021-04-28T12:13:24-04:00 0.5 https://investors.puretechhealth.com/news-releases/news-release-details/puretech-forms-clinical-advisory-board-idiopathic-pulmonary 2021-05-12T07:03:49-04:00 0.5 https://investors.puretechhealth.com/news-releases/news-release-details/puretech-present-jefferies-virtual-healthcare-conference-0 2021-05-25T07:02:12-04:00 0.5 https://investors.puretechhealth.com/news-releases/news-release-details/puretech-founded-entity-akili-secures-160-million-financing 2021-05-26T08:47:15-04:00 0.5 https://investors.puretechhealth.com/news-releases/news-release-details/puretech-founded-entity-gelesis-presents-findings-plenityr 2021-05-27T09:52:20-04:00 0.5 https://investors.puretechhealth.com/news-releases/news-release-details/results-annual-general-meeting-2 2021-05-27T13:32:56-04:00 0.5 https://investors.puretechhealth.com/news-releases/news-release-details/puretech-acquires-remaining-interest-founded-entity-alivio 2021-06-16T07:44:23-04:00 0.5 https://investors.puretechhealth.com/news-releases/news-release-details/puretech-founded-entity-karuna-therapeutics-announces-results 2021-06-23T08:42:02-04:00 0.5 https://investors.puretechhealth.com/news-releases/news-release-details/puretech-founded-entity-vedanta-biosciences-announces-new-data 2021-06-30T07:03:29-04:00 0.5 https://investors.puretechhealth.com/news-releases/news-release-details/puretech-announces-clinical-trial-and-supply-agreement-beigene 2024-04-03T17:28:05-04:00 0.5 https://investors.puretechhealth.com/news-releases/news-release-details/science-translational-medicine-inflammation-targeting-hydrogel 2021-07-07T18:07:38-04:00 0.5 https://investors.puretechhealth.com/news-releases/news-release-details/science-translational-medicine-single-localized-dose-enzyme 2021-07-07T18:08:40-04:00 0.5 https://investors.puretechhealth.com/news-releases/news-release-details/journal-biomedical-materials-research-demand-drug-delivery-self 2021-07-09T17:17:27-04:00 0.5 https://investors.puretechhealth.com/news-releases/news-release-details/biomaterials-self-assembled-prodrugs-enzymatically-triggered 2021-07-07T18:11:34-04:00 0.5 https://investors.puretechhealth.com/news-releases/news-release-details/pharmaceutical-research-profiling-role-deacylation-reacylation 2021-07-07T18:12:21-04:00 0.5 https://investors.puretechhealth.com/news-releases/news-release-details/nature-reviews-materials-oral-delivery-proteins-and-peptides 2021-07-07T18:13:09-04:00 0.5 https://investors.puretechhealth.com/news-releases/news-release-details/journal-clinical-investigation-understanding-functions-and 2021-07-07T18:13:55-04:00 0.5 https://investors.puretechhealth.com/news-releases/news-release-details/nature-unexpected-role-interferon-g-regulating-neuronal 2021-07-07T18:14:53-04:00 0.5 https://investors.puretechhealth.com/news-releases/news-release-details/nature-structural-and-functional-features-central-nervous-system 2021-07-07T18:15:33-04:00 0.5 https://investors.puretechhealth.com/news-releases/news-release-details/trends-immunology-revisiting-mechanisms-cns-immune-privilege 2021-07-07T18:16:19-04:00 0.5 https://investors.puretechhealth.com/news-releases/news-release-details/journal-neurogastroenterology-and-motility-csp01-novel 2021-07-07T18:17:17-04:00 0.5 https://investors.puretechhealth.com/news-releases/news-release-details/obesity-journal-randomized-double-blind-placebo-controlled-study 2021-07-07T18:18:04-04:00 0.5 https://investors.puretechhealth.com/news-releases/news-release-details/canadian-journal-physiology-and-pharmacology-effect-nonsystemic 2021-07-07T18:19:15-04:00 0.5 https://investors.puretechhealth.com/news-releases/news-release-details/american-journal-clinical-nutrition-pretreatment-fasting-plasma 2021-07-07T18:19:49-04:00 0.5 https://investors.puretechhealth.com/news-releases/news-release-details/molecular-pharmaceutics-lymphatic-transport-and-lymphocyte-0 2021-07-07T18:20:24-04:00 0.5 https://investors.puretechhealth.com/news-releases/news-release-details/puretech-founded-entity-sonde-health-announces-collaboration 2021-07-09T15:08:36-04:00 0.5 https://investors.puretechhealth.com/news-releases/news-release-details/puretech-founded-entity-vor-biopharma-announces-collaboration 2021-07-09T07:02:29-04:00 0.5 https://investors.puretechhealth.com/news-releases/news-release-details/early-infancy-microbial-and-metabolic-alterations-affect-risk 2021-07-12T13:02:28-04:00 0.5 https://investors.puretechhealth.com/news-releases/news-release-details/journal-medical-internet-research-use-and-effectiveness-mobile 2021-07-12T11:54:46-04:00 0.5 https://investors.puretechhealth.com/news-releases/news-release-details/nature-games-do-you-good 2021-07-12T11:56:14-04:00 0.5 https://investors.puretechhealth.com/news-releases/news-release-details/nanomedicine-milk-derived-exosomes-oral-delivery-paclitaxel 2021-07-12T15:32:30-04:00 0.5 https://investors.puretechhealth.com/news-releases/news-release-details/cancer-letters-exosomal-formulation-anthocyanidins-against 2021-07-12T15:33:37-04:00 0.5 https://investors.puretechhealth.com/news-releases/news-release-details/cancer-letters-bovine-milk-derived-exosomes-drug-delivery 2021-07-12T15:35:27-04:00 0.5 https://investors.puretechhealth.com/news-releases/news-release-details/journal-nutrition-micrornas-are-absorbed-biologically-meaningful 2021-07-12T15:36:42-04:00 0.5 https://investors.puretechhealth.com/news-releases/news-release-details/puretech-founded-entity-gelesis-maker-plenityr-become-publicly 2021-07-19T07:39:51-04:00 0.5 https://investors.puretechhealth.com/news-releases/news-release-details/puretech-founded-entity-vedanta-biosciences-completes-68-million 2021-07-21T07:07:14-04:00 0.5 https://investors.puretechhealth.com/news-releases/news-release-details/puretech-founded-entity-akili-releases-new-gameplay-features 2021-08-17T09:49:36-04:00 0.5 https://investors.puretechhealth.com/news-releases/news-release-details/notice-half-yearly-results-3 2021-08-03T02:04:25-04:00 0.5 https://investors.puretechhealth.com/news-releases/news-release-details/puretech-announces-imbrium-therapeutics-has-exercised-license 2022-09-23T10:11:44-04:00 0.5 https://investors.puretechhealth.com/news-releases/news-release-details/puretech-announces-appointment-julie-krop-md-chief-medical 2021-08-13T07:03:22-04:00 0.5 https://investors.puretechhealth.com/news-releases/news-release-details/puretech-founded-entity-akili-enters-strategic-licensing 2021-08-17T08:06:22-04:00 0.5 https://investors.puretechhealth.com/news-releases/news-release-details/puretech-presents-phase-1-data-lyt-100-european-respiratory 2022-09-23T09:47:30-04:00 0.5 https://investors.puretechhealth.com/news-releases/news-release-details/puretech-health-2021-half-year-report 2021-08-24T02:24:57-04:00 0.5 https://investors.puretechhealth.com/news-releases/news-release-details/puretech-founded-entity-vor-biopharma-announces-vor33-granted-us 2021-10-12T13:46:08-04:00 0.5 https://investors.puretechhealth.com/news-releases/news-release-details/puretech-present-oppenheimer-fall-healthcare-life-sciences-and 2021-09-14T07:01:37-04:00 0.5 https://investors.puretechhealth.com/news-releases/news-release-details/puretech-announces-publication-new-preclinical-research 2022-09-23T10:15:31-04:00 0.5 https://investors.puretechhealth.com/news-releases/news-release-details/puretech-founded-entity-akili-announces-topline-results-shionogi 2021-09-29T08:06:09-04:00 0.5 https://investors.puretechhealth.com/news-releases/news-release-details/puretech-founded-entity-sonde-health-launches-vocal-biomarker 2021-10-05T08:02:47-04:00 0.5 https://investors.puretechhealth.com/news-releases/news-release-details/puretech-founded-entity-vedanta-announces-positive-topline-phase 2021-10-05T08:08:29-04:00 0.5 https://investors.puretechhealth.com/news-releases/news-release-details/nature-metabolism-mesenteric-lymphatic-dysfunction-promotes 2021-10-11T15:45:53-04:00 0.5 https://investors.puretechhealth.com/news-releases/news-release-details/puretech-founded-entity-vedanta-biosciences-appoints-simona-levi 2021-10-14T08:54:07-04:00 0.5 https://investors.puretechhealth.com/news-releases/news-release-details/puretech-pleased-note-publication-natures-scientific-reports 2021-11-01T06:23:14-04:00 0.5 https://investors.puretechhealth.com/news-releases/news-release-details/biomimetic-cellulose-based-superabsorbent-hydrogels-treating 2021-11-16T10:20:50-05:00 0.5 https://investors.puretechhealth.com/news-releases/news-release-details/puretech-announces-participation-jefferies-london-healthcare 2021-11-09T02:03:31-05:00 0.5 https://investors.puretechhealth.com/news-releases/news-release-details/puretech-founded-entity-karuna-therapeutics-and-zai-lab-announce 2021-11-09T07:38:01-05:00 0.5 https://investors.puretechhealth.com/news-releases/news-release-details/puretech-receives-approximately-100-million-sale-minority-0 2021-11-10T02:08:04-05:00 0.5 https://investors.puretechhealth.com/news-releases/news-release-details/puretech-receives-orphan-drug-designation-wholly-owned-candidate 2024-04-03T17:28:02-04:00 0.5 https://investors.puretechhealth.com/news-releases/news-release-details/puretech-presents-clinical-trial-design-supporting-wholly-owned 2024-04-03T17:27:56-04:00 0.5 https://investors.puretechhealth.com/news-releases/news-release-details/puretech-announces-participation-two-upcoming-investor 2021-11-15T07:04:20-05:00 0.5 https://investors.puretechhealth.com/news-releases/news-release-details/puretech-announces-publication-phase-1-results-lyt-100-journal 2022-09-23T09:46:53-04:00 0.5 https://investors.puretechhealth.com/news-releases/news-release-details/clinical-pharmacology-drug-development-randomized-phase-1 2025-10-21T16:35:47-04:00 0.5 https://investors.puretechhealth.com/news-releases/news-release-details/puretech-founded-entity-gelesis-receives-30-million-plenityr 2021-11-18T07:14:00-05:00 0.5 https://investors.puretechhealth.com/news-releases/news-release-details/puretech-founded-entity-gelesis-announces-fda-cleared-weight 2021-12-01T12:30:58-05:00 0.5 https://investors.puretechhealth.com/news-releases/news-release-details/puretech-advances-wholly-owned-candidate-lyt-300-oral 2024-04-03T17:19:28-04:00 0.5 https://investors.puretechhealth.com/news-releases/news-release-details/puretech-presents-preclinical-proof-concept-data-lyt-300-oral 2024-04-03T17:19:22-04:00 0.5 https://investors.puretechhealth.com/news-releases/news-release-details/puretech-provides-end-year-report-key-progress-across-wholly 2021-12-16T02:19:46-05:00 0.5 https://investors.puretechhealth.com/news-releases/news-release-details/puretech-founded-entity-gelesis-appoints-inogen-co-founder-and 2022-01-05T07:09:33-05:00 0.5 https://investors.puretechhealth.com/news-releases/news-release-details/puretechs-lyt-100-deupirfenidone-achieves-50-reduction-healthy 2022-09-23T09:46:11-04:00 0.5 https://investors.puretechhealth.com/news-releases/news-release-details/puretech-present-40th-annual-jp-morgan-healthcare-conference 2022-01-07T07:03:30-05:00 0.5 https://investors.puretechhealth.com/news-releases/news-release-details/puretech-founded-entity-gelesis-maker-plenityr-weight-management 2022-01-14T02:04:24-05:00 0.5 https://investors.puretechhealth.com/news-releases/news-release-details/puretech-founded-entity-akili-interactive-leader-digital 2022-01-26T07:05:51-05:00 0.5 https://investors.puretechhealth.com/news-releases/news-release-details/puretech-founded-entity-gelesis-launch-plenityr-national-media 2022-01-31T06:58:15-05:00 0.5 https://investors.puretechhealth.com/news-releases/news-release-details/puretech-present-svb-leerink-11th-annual-global-healthcare 2022-02-10T07:08:32-05:00 0.5 https://investors.puretechhealth.com/news-releases/news-release-details/puretech-founded-entity-akili-interactive-announces-filing 2022-02-15T02:05:58-05:00 0.5 https://investors.puretechhealth.com/news-releases/news-release-details/puretech-founded-entity-akili-announces-plos-one-publication 2022-02-17T07:18:43-05:00 0.5 https://investors.puretechhealth.com/news-releases/news-release-details/puretech-founded-entity-akili-named-fast-companys-annual-list 2022-03-08T07:08:50-05:00 0.5 https://investors.puretechhealth.com/news-releases/news-release-details/puretech-founded-entity-gelesisr-releases-preliminary-national 2022-03-16T06:37:22-04:00 0.5 https://investors.puretechhealth.com/news-releases/news-release-details/puretech-founded-entity-akili-appoints-game-industry-veteran 2022-03-17T09:08:11-04:00 0.5 https://investors.puretechhealth.com/news-releases/news-release-details/puretech-appoints-sharon-barber-lui-board-directors-audit 2022-03-24T03:04:33-04:00 0.5 https://investors.puretechhealth.com/news-releases/news-release-details/puretech-health-notice-results 2022-04-07T02:03:55-04:00 0.5 https://investors.puretechhealth.com/news-releases/news-release-details/puretech-announces-publication-research-collaborators 2022-09-23T10:15:01-04:00 0.5 https://investors.puretechhealth.com/news-releases/news-release-details/puretech-founded-entity-akili-announces-american-journal 2022-04-12T07:09:03-04:00 0.5 https://investors.puretechhealth.com/news-releases/news-release-details/puretech-founded-entity-vedanta-biosciences-publishes-phase-1a1b 2022-04-13T11:53:41-04:00 0.5 https://investors.puretechhealth.com/news-releases/news-release-details/cell-host-microbe-colonization-live-biotherapeutic-product-ve303 2022-04-15T16:11:15-04:00 0.5 https://investors.puretechhealth.com/news-releases/news-release-details/frontiers-pharmacology-triglyceride-mimetic-prodrugs 2022-04-15T16:12:07-04:00 0.5 https://investors.puretechhealth.com/news-releases/news-release-details/american-journal-psychiatry-digital-intervention-cognitive 2022-04-15T16:13:08-04:00 0.5 https://investors.puretechhealth.com/news-releases/news-release-details/plos-one-enhancing-neural-markers-attention-children-adhd-using 2022-04-15T16:14:31-04:00 0.5 https://investors.puretechhealth.com/news-releases/news-release-details/puretech-announces-annual-results-year-ended-december-31-2021 2022-04-26T02:11:08-04:00 0.5 https://investors.puretechhealth.com/news-releases/news-release-details/puretech-founded-entity-gelesis-announces-its-proprietary 2022-04-29T06:11:45-04:00 0.5 https://investors.puretechhealth.com/news-releases/news-release-details/puretech-founded-entity-gelesis-announces-clinical-data 2022-05-04T06:37:13-04:00 0.5 https://investors.puretechhealth.com/news-releases/news-release-details/puretech-announces-share-buyback-programme-50-million 2022-05-05T02:03:38-04:00 0.5 https://investors.puretechhealth.com/news-releases/news-release-details/puretech-announces-share-buyback-programme-update 2022-05-09T02:04:59-04:00 0.5 https://investors.puretechhealth.com/news-releases/news-release-details/puretech-presents-additional-phase-1-data-lyt-100-american 2022-09-23T09:45:08-04:00 0.5 https://investors.puretechhealth.com/news-releases/news-release-details/puretech-present-ubs-global-healthcare-conference 2022-05-17T07:02:55-04:00 0.5 https://investors.puretechhealth.com/news-releases/news-release-details/puretech-founded-entity-vedanta-biosciences-presents-data 2022-05-24T03:07:54-04:00 0.5 https://investors.puretechhealth.com/news-releases/news-release-details/puretech-founded-entity-akili-integrates-first-its-kind 2022-05-26T07:07:31-04:00 0.5 https://investors.puretechhealth.com/news-releases/news-release-details/puretech-present-jefferies-healthcare-conference 2022-06-01T07:02:14-04:00 0.5 https://investors.puretechhealth.com/news-releases/news-release-details/puretech-founded-entity-gelesis-presents-study-proprietary 2022-06-06T07:02:54-04:00 0.5 https://investors.puretechhealth.com/news-releases/news-release-details/puretech-founded-entity-akili-appoints-life-sciences-veteran 2022-06-06T07:09:33-04:00 0.5 https://investors.puretechhealth.com/news-releases/news-release-details/puretech-reports-results-phase-2-study-lyt-100-cov-post-acute 2022-09-23T09:44:22-04:00 0.5 https://investors.puretechhealth.com/news-releases/news-release-details/puretech-meets-milestone-achieving-oral-bioavailability 2024-04-03T17:19:19-04:00 0.5 https://investors.puretechhealth.com/news-releases/news-release-details/results-annual-general-meeting-3 2022-07-01T03:40:09-04:00 0.5 https://investors.puretechhealth.com/news-releases/news-release-details/puretech-founded-entity-gelesis-announces-additional-15-million 2022-06-24T15:02:04-04:00 0.5 https://investors.puretechhealth.com/news-releases/news-release-details/prtcs-vedanta-unveils-new-manufacturing-facility 2022-07-01T03:25:20-04:00 0.5 https://investors.puretechhealth.com/news-releases/news-release-details/puretech-initiates-late-stage-clinical-study-wholly-owned 2024-11-25T15:01:23-05:00 0.5 https://investors.puretechhealth.com/news-releases/news-release-details/puretech-founded-entity-akili-announces-public-company-board 2022-07-11T07:07:41-04:00 0.5 https://investors.puretechhealth.com/news-releases/news-release-details/puretech-founded-entity-akili-announces-journal-lupus-publishes 2022-07-14T08:44:13-04:00 0.5 https://investors.puretechhealth.com/news-releases/news-release-details/puretech-founded-entity-akili-announces-phase-3-study-digital 2022-08-01T07:09:02-04:00 0.5 https://investors.puretechhealth.com/news-releases/news-release-details/notice-half-yearly-results-4 2022-08-04T02:04:23-04:00 0.5 https://investors.puretechhealth.com/news-releases/news-release-details/karuna-successful-ph3-karxt-study-schizophrenia 2022-08-19T11:23:52-04:00 0.5 https://investors.puretechhealth.com/news-releases/news-release-details/puretech-receive-approximately-1154-million-sale-portion-founded 2022-08-09T02:14:34-04:00 0.5 https://investors.puretechhealth.com/news-releases/news-release-details/puretech-founded-entity-akili-list-nasdaq-following-successful 2022-08-22T11:24:39-04:00 0.5 https://investors.puretechhealth.com/news-releases/news-release-details/puretech-health-plc-half-year-report 2022-08-25T03:13:01-04:00 0.5 https://investors.puretechhealth.com/news-releases/news-release-details/puretech-founded-entity-gelesis-presented-clinical-data-light 2022-08-25T11:50:30-04:00 0.5 https://investors.puretechhealth.com/news-releases/news-release-details/puretech-presents-data-lyt-100-deupirfenidone-supporting-design 2022-09-23T09:43:39-04:00 0.5 https://investors.puretechhealth.com/news-releases/news-release-details/puretech-present-morgan-stanley-global-healthcare-conference 2022-09-08T07:04:12-04:00 0.5 https://investors.puretechhealth.com/news-releases/news-release-details/statement-regarding-recent-press-speculation 2022-10-06T19:09:53-04:00 0.5 https://investors.puretechhealth.com/news-releases/news-release-details/statement-regarding-termination-discussions-nektar-0 2022-10-11T02:07:20-04:00 0.5 https://investors.puretechhealth.com/news-releases/news-release-details/puretech-present-credit-suisse-31st-annual-healthcare-conference 2022-11-01T07:20:07-04:00 0.5 https://investors.puretechhealth.com/news-releases/news-release-details/puretech-founded-entity-gelesis-announces-two-presentations 2022-11-02T07:55:00-04:00 0.5 https://investors.puretechhealth.com/news-releases/news-release-details/puretech-present-jefferies-london-healthcare-conference 2022-11-09T07:01:55-05:00 0.5 https://investors.puretechhealth.com/news-releases/news-release-details/puretech-present-two-upcoming-investor-conferences-0 2022-11-17T07:02:17-05:00 0.5 https://investors.puretechhealth.com/news-releases/news-release-details/puretech-announces-new-therapeutic-candidate-lyt-310-oral-form 2024-04-03T17:21:07-04:00 0.5 https://investors.puretechhealth.com/news-releases/news-release-details/puretech-founded-entity-vor-bio-announces-first-aml-patient 2022-12-07T10:04:27-05:00 0.5 https://investors.puretechhealth.com/news-releases/news-release-details/puretech-founded-entity-sonde-health-raises-1925-million-series 2022-12-09T08:16:22-05:00 0.5 https://investors.puretechhealth.com/news-releases/news-release-details/puretech-presents-data-lyt-200-targeting-galectin-9-preclinical 2024-04-03T17:27:48-04:00 0.5 https://investors.puretechhealth.com/news-releases/news-release-details/puretech-present-41st-annual-jp-morgan-healthcare-conference 2022-12-13T07:02:32-05:00 0.5 https://investors.puretechhealth.com/news-releases/news-release-details/puretechs-lyt-300-oral-allopregnanolone-demonstrates-oral 2024-04-03T17:19:14-04:00 0.5 https://investors.puretechhealth.com/news-releases/news-release-details/puretech-provides-end-year-report-key-progress 2022-12-22T03:09:33-05:00 0.5 https://investors.puretechhealth.com/news-releases/news-release-details/puretech-founded-entity-akili-announces-pivotal-trial 2023-01-06T02:07:06-05:00 0.5 https://investors.puretechhealth.com/news-releases/news-release-details/puretech-present-svb-securities-global-biopharma-conference 2023-02-01T07:18:49-05:00 0.5 https://investors.puretechhealth.com/news-releases/news-release-details/puretech-advance-lyt-300-oral-allopregnanolone-potential 2024-04-03T17:19:10-04:00 0.5 https://investors.puretechhealth.com/news-releases/news-release-details/puretech-founded-entity-sonde-health-and-massachusetts-general 2023-02-27T09:40:27-05:00 0.5 https://investors.puretechhealth.com/news-releases/news-release-details/puretech-present-barclays-global-healthcare-conference-0 2023-03-01T09:28:54-05:00 0.5 https://investors.puretechhealth.com/news-releases/news-release-details/puretech-founded-entity-karuna-therapeutics-announces-positive 2023-03-20T07:50:39-04:00 0.5 https://investors.puretechhealth.com/news-releases/news-release-details/prtc-gets-500m-rprx-karxt-royalty 2023-05-30T16:01:01-04:00 0.5 https://investors.puretechhealth.com/news-releases/news-release-details/puretech-health-notice-results-0 2023-04-13T02:05:47-04:00 0.5 https://investors.puretechhealth.com/news-releases/news-release-details/puretech-founded-entity-vedanta-biosciences-publishes-phase-2 2023-05-10T13:57:00-04:00 0.5 https://investors.puretechhealth.com/news-releases/news-release-details/puretech-founded-entity-vedanta-biosciences-announces-1065 2023-05-10T13:56:54-04:00 0.5 https://investors.puretechhealth.com/news-releases/news-release-details/puretech-announces-annual-results-year-ended-december-31-2022 2023-04-28T02:06:26-04:00 0.5 https://investors.puretechhealth.com/news-releases/news-release-details/puretech-founded-entity-akili-announces-adults-adhd-see 2023-05-10T13:56:49-04:00 0.5 https://investors.puretechhealth.com/news-releases/news-release-details/puretech-founded-entity-vedanta-biosciences-receives-fast-track 2023-05-10T13:56:45-04:00 0.5 https://investors.puretechhealth.com/news-releases/news-release-details/puretech-founded-entity-sonde-health-announces-respiratory 2023-05-23T09:07:14-04:00 0.5 https://investors.puretechhealth.com/news-releases/news-release-details/puretech-present-jefferies-healthcare-conference-0 2023-05-24T07:04:00-04:00 0.5 https://investors.puretechhealth.com/news-releases/news-release-details/puretech-founded-entity-akili-releases-endeavorotctm-video-game 2023-06-07T07:14:28-04:00 0.5 https://investors.puretechhealth.com/news-releases/news-release-details/ve303-defined-bacterial-consortium-prevention-recurrent 2023-06-07T15:30:35-04:00 0.5 https://investors.puretechhealth.com/news-releases/news-release-details/results-annual-general-meeting-4 2023-06-13T12:19:58-04:00 0.5 https://investors.puretechhealth.com/news-releases/news-release-details/puretech-initiates-phase-2a-clinical-trial-lyt-300-oral 2024-04-03T17:19:05-04:00 0.5 https://investors.puretechhealth.com/news-releases/news-release-details/puretech-awarded-114-million-us-department-defense-advance-lyt 2024-04-03T17:19:01-04:00 0.5 https://investors.puretechhealth.com/news-releases/news-release-details/notice-half-yearly-results-5 2023-08-22T02:12:25-04:00 0.5 https://investors.puretechhealth.com/news-releases/news-release-details/puretech-health-plc-half-year-report-0 2023-08-29T02:42:46-04:00 0.5 https://investors.puretechhealth.com/news-releases/news-release-details/prtc-names-robert-lyne-chief-portfolio-officer 2023-09-27T02:30:19-04:00 0.5 https://investors.puretechhealth.com/news-releases/news-release-details/karxt-invented-puretech-submitted-fda-approval-schizophrenia 2024-08-01T10:50:40-04:00 0.5 https://investors.puretechhealth.com/news-releases/news-release-details/puretech-founded-entity-vedanta-biosciences-announces-first 2024-08-01T10:49:39-04:00 0.5 https://investors.puretechhealth.com/news-releases/news-release-details/puretech-presents-data-lyt-100-deupirfenidone-trial-healthy 2024-08-01T10:48:58-04:00 0.5 https://investors.puretechhealth.com/news-releases/news-release-details/puretech-present-two-upcoming-investor-conferences-1 2023-10-17T02:10:05-04:00 0.5 https://investors.puretechhealth.com/news-releases/news-release-details/puretechs-lyt-300-oral-allopregnanolone-achieved-primary 2024-04-03T17:18:55-04:00 0.5 https://investors.puretechhealth.com/news-releases/news-release-details/puretech-founded-entity-karuna-therapeutics-announces-positive-0 2024-08-01T10:46:41-04:00 0.5 https://investors.puretechhealth.com/news-releases/news-release-details/puretech-founded-entity-karuna-therapeutics-announces-us-food 2024-08-01T10:46:01-04:00 0.5 https://investors.puretechhealth.com/news-releases/news-release-details/puretech-presents-data-phase-1-trial-lyt-200-targeting-galectin 2024-04-03T17:27:41-04:00 0.5 https://investors.puretechhealth.com/news-releases/news-release-details/puretech-year-end-update-and-outlook-2024 2024-01-04T14:48:47-05:00 0.5 https://investors.puretechhealth.com/news-releases/news-release-details/puretech-founded-entity-karuna-therapeutics-be-acquired-bristol 2023-12-22T08:46:41-05:00 0.5 https://investors.puretechhealth.com/news-releases/news-release-details/puretech-present-42nd-annual-jp-morgan-healthcare-conference 2024-01-03T07:03:02-05:00 0.5 https://investors.puretechhealth.com/news-releases/news-release-details/puretech-founded-entity-akili-announces-positive-results 2024-08-01T10:45:12-04:00 0.5 https://investors.puretechhealth.com/news-releases/news-release-details/puretech-present-two-upcoming-investor-conferences-2 2024-02-27T07:04:48-05:00 0.5 https://investors.puretechhealth.com/news-releases/news-release-details/validating-efficacy-and-value-proposition-mental-fitness-vocal 2024-04-15T20:45:28-04:00 0.5 https://investors.puretechhealth.com/news-releases/news-release-details/puretech-receives-orphan-drug-designation-lyt-200-acute-myeloid 2024-03-13T13:08:46-04:00 0.5 https://investors.puretechhealth.com/news-releases/news-release-details/14b-acquisition-prtcs-karuna-bms-completed 2024-03-18T09:44:47-04:00 0.5 https://investors.puretechhealth.com/news-releases/news-release-details/puretech-proposes-100-million-capital-return 2024-03-19T03:11:32-04:00 0.5 https://investors.puretechhealth.com/news-releases/news-release-details/puretech-launches-seaport-therapeutics-with-%24100-million-oversubscribed-series-a-and-announces-management-transitions 2024-04-09T02:08:22-04:00 0.5 https://investors.puretechhealth.com/news-releases/news-release-details/puretech-receives-fda-fast-track-designation-lyt-200-head-and 2024-04-11T07:06:26-04:00 0.5 https://investors.puretechhealth.com/news-releases/news-release-details/puretech-announces-completion-enrollment-phase-2b-elevate-ipf 2024-08-01T10:44:34-04:00 0.5 https://investors.puretechhealth.com/news-releases/news-release-details/puretech-health-notice-results-1 2024-04-18T02:03:55-04:00 0.5 https://investors.puretechhealth.com/news-releases/news-release-details/puretech-announces-annual-results-year-ended-december-31-2023 2024-04-25T06:19:31-04:00 0.5 https://investors.puretechhealth.com/news-releases/news-release-details/puretech-founded-entity-seaport-therapeutics-adds-industry 2024-08-01T10:43:38-04:00 0.5 https://investors.puretechhealth.com/news-releases/news-release-details/puretech-founded-entity-seaport-therapeutics-presents-data 2024-08-01T10:43:01-04:00 0.5 https://investors.puretechhealth.com/news-releases/news-release-details/launch-proposed-100-million-tender-offer-250-pence-ordinary 2024-05-20T17:10:39-04:00 0.5 https://investors.puretechhealth.com/news-releases/news-release-details/puretech-founded-entity-vedanta-biosciences-enrolls-first 2024-08-01T10:42:08-04:00 0.5 https://investors.puretechhealth.com/news-releases/news-release-details/puretech-present-jefferies-global-healthcare-conference 2024-05-23T07:02:40-04:00 0.5 https://investors.puretechhealth.com/news-releases/news-release-details/puretech-founded-entity-akili-interactive-and-virtual 2024-06-06T14:09:03-04:00 0.5 https://investors.puretechhealth.com/news-releases/news-release-details/result-meeting 2024-06-06T13:14:45-04:00 0.5 https://investors.puretechhealth.com/news-releases/news-release-details/results-annual-general-meeting-5 2024-06-13T12:56:57-04:00 0.5 https://investors.puretechhealth.com/news-releases/news-release-details/puretech-founded-entity-seaport-therapeutics-appoints-seasoned 2024-06-18T08:17:50-04:00 0.5 https://investors.puretechhealth.com/news-releases/news-release-details/puretech-announces-change-board-role 2024-06-20T02:08:38-04:00 0.5 https://investors.puretechhealth.com/news-releases/news-release-details/results-tender-offer 2024-06-24T02:03:35-04:00 0.5 https://investors.puretechhealth.com/news-releases/news-release-details/puretech-health-completion-tender-offer-total-voting-rights 2024-07-25T17:08:04-04:00 0.5 https://investors.puretechhealth.com/news-releases/news-release-details/puretech-founded-entity-vedanta-biosciences-expands-leadership 2024-07-23T15:55:30-04:00 0.5 https://investors.puretechhealth.com/news-releases/news-release-details/puretech-founded-entity-seaport-therapeutics-appoints-david 2024-08-13T07:09:23-04:00 0.5 https://investors.puretechhealth.com/news-releases/news-release-details/notice-results-5 2024-08-21T02:04:44-04:00 0.5 https://investors.puretechhealth.com/news-releases/news-release-details/puretech-appoints-michele-holcomb-phd-board-directors 2024-08-22T02:06:16-04:00 0.5 https://investors.puretechhealth.com/news-releases/news-release-details/results-annual-general-meeting-13-june-2024-update-statement 2024-08-28T02:12:41-04:00 0.5 https://investors.puretechhealth.com/news-releases/news-release-details/puretech-health-plc-half-year-report-1 2024-08-28T02:16:37-04:00 0.5 https://investors.puretechhealth.com/news-releases/news-release-details/puretech-founded-entity-vor-bio-announces-new-clinical-data 2024-09-06T02:54:11-04:00 0.5 https://investors.puretechhealth.com/news-releases/news-release-details/puretech-founded-entity-vor-bio-announces-new-clinical-data-0 2024-09-06T02:10:43-04:00 0.5 https://investors.puretechhealth.com/news-releases/news-release-details/puretech-invented-karxt-receives-us-food-and-drug-administration 2024-09-27T02:09:46-04:00 0.5 https://investors.puretechhealth.com/news-releases/news-release-details/puretech-present-chest-2024-annual-meeting 2024-10-01T07:06:12-04:00 0.5 https://investors.puretechhealth.com/news-releases/news-release-details/puretech-presents-research-highlighting-burden-idiopathic 2024-10-09T02:15:13-04:00 0.5 https://investors.puretechhealth.com/news-releases/news-release-details/puretech-founded-entity-seaport-therapeutics-closes-225-million 2024-10-21T02:05:26-04:00 0.5 https://investors.puretechhealth.com/news-releases/news-release-details/puretech-present-two-upcoming-investor-conferences-3 2024-10-30T18:11:31-04:00 0.5 https://investors.puretechhealth.com/news-releases/news-release-details/puretech-founded-entity-seaport-therapeutics-names-lauren-white 2024-11-06T22:10:59-05:00 0.5 https://investors.puretechhealth.com/news-releases/news-release-details/puretech-founded-entity-seaport-therapeutics-adds-sandi-peterson 2024-11-20T07:13:15-05:00 0.5 https://investors.puretechhealth.com/news-releases/news-release-details/puretech-presents-data-lyt-200-anti-galectin-9-monoclonal 2024-12-09T02:04:16-05:00 0.5 https://investors.puretechhealth.com/news-releases/news-release-details/puretech-founded-entity-seaport-therapeutics-presents-additional 2024-12-11T07:13:01-05:00 0.5 https://investors.puretechhealth.com/news-releases/news-release-details/puretechs-deupirfenidone-lyt-100-slowed-lung-function-decline 2024-12-16T02:26:23-05:00 0.5 https://investors.puretechhealth.com/news-releases/news-release-details/puretech-appoints-ubs-corporate-broker 2025-01-06T02:14:14-05:00 0.5 https://investors.puretechhealth.com/news-releases/news-release-details/puretech-present-43rd-annual-jp-morgan-healthcare-conference 2025-01-08T07:06:58-05:00 0.5 https://investors.puretechhealth.com/news-releases/news-release-details/puretech-receives-fda-fast-track-designation-lyt-200-acute 2025-01-09T07:07:44-05:00 0.5 https://investors.puretechhealth.com/news-releases/news-release-details/puretech-founded-vedanta-biosciences-publishes-additional-phase 2025-01-27T02:23:00-05:00 0.5 https://investors.puretechhealth.com/news-releases/news-release-details/puretech-founded-entity-seaport-therapeutics-announces 2025-02-12T09:59:17-05:00 0.5 https://investors.puretechhealth.com/news-releases/news-release-details/molecular-pharmaceutics-optimizing-triglyceride-prodrugs-model 2025-02-12T10:02:05-05:00 0.5 https://investors.puretechhealth.com/news-releases/news-release-details/puretech-present-leerink-partners-global-healthcare-conference 2025-02-25T17:10:59-05:00 0.5 https://investors.puretechhealth.com/news-releases/news-release-details/puretech-founded-entity-seaport-therapeutics-appoints-robert-j 2025-03-11T07:09:56-04:00 0.5 https://investors.puretechhealth.com/news-releases/news-release-details/statement-re-possible-offer 2025-04-07T12:05:21-04:00 0.5 https://investors.puretechhealth.com/news-releases/news-release-details/puretech-appoints-peel-hunt-joint-uk-corporate-broker 2025-04-09T02:08:01-04:00 0.5 https://investors.puretechhealth.com/news-releases/news-release-details/notice-results-6 2025-04-23T02:22:47-04:00 0.5 https://investors.puretechhealth.com/news-releases/news-release-details/puretech-announces-annual-results-year-ended-december-31-2024 2025-04-30T06:27:30-04:00 0.5 https://investors.puretechhealth.com/news-releases/news-release-details/puretech-present-results-phase-2b-elevate-ipf-trial 2025-05-07T15:35:12-04:00 0.5 https://investors.puretechhealth.com/news-releases/news-release-details/perspectives-people-living-idiopathic-pulmonary-fibrosis 2025-05-09T07:12:00-04:00 0.5 https://investors.puretechhealth.com/news-releases/news-release-details/puretech-announces-publication-new-research-highlighting-untold 2025-05-09T07:05:43-04:00 0.5 https://investors.puretechhealth.com/news-releases/news-release-details/puretechs-deupirfenidone-lyt-100-demonstrates-strong-and-durable 2025-06-17T11:30:38-04:00 0.5 https://investors.puretechhealth.com/news-releases/news-release-details/puretech-present-jefferies-global-healthcare-conference-0 2025-05-22T07:07:20-04:00 0.5 https://investors.puretechhealth.com/news-releases/news-release-details/results-annual-general-meeting-6 2025-06-16T12:51:57-04:00 0.5 https://investors.puretechhealth.com/news-releases/news-release-details/puretech-founded-entity-vor-bio-announces-exclusive-global 2025-06-26T02:08:44-04:00 0.5 https://investors.puretechhealth.com/news-releases/news-release-details/puretech-announces-board-change-2 2025-07-08T12:52:34-04:00 0.5 https://investors.puretechhealth.com/news-releases/news-release-details/puretech-announces-leadership-transition 2025-07-16T02:12:55-04:00 0.5 https://investors.puretechhealth.com/news-releases/news-release-details/puretech-founded-entity-seaport-therapeutics-announces-first 2025-07-17T07:21:12-04:00 0.5 https://investors.puretechhealth.com/news-releases/news-release-details/puretech-announces-launch-celea-therapeutics-mission-transform 2025-08-12T07:39:39-04:00 0.5 https://investors.puretechhealth.com/news-releases/news-release-details/puretech-founded-entity-vedanta-biosciences-announces-phase-2 2025-08-13T12:33:48-04:00 0.5 https://investors.puretechhealth.com/news-releases/news-release-details/notice-half-yearly-results-6 2025-08-18T02:09:39-04:00 0.5 https://investors.puretechhealth.com/news-releases/news-release-details/puretech-showcases-differentiated-development-strategy-including 2025-08-21T07:16:34-04:00 0.5 https://investors.puretechhealth.com/news-releases/news-release-details/puretech-health-plc-half-year-report-2 2025-08-28T02:07:02-04:00 0.5 https://investors.puretechhealth.com/news-releases/news-release-details/puretech-founded-entity-seaport-therapeutics-advances-second 2025-09-11T07:11:46-04:00 0.5 https://investors.puretechhealth.com/news-releases/news-release-details/puretech-presents-new-data-phase-2b-open-label-extension-study 2025-09-29T10:18:25-04:00 0.5 https://investors.puretechhealth.com/news-releases/news-release-details/puretech-presents-new-phase-2b-analyses-demonstrating-consistent 2025-10-22T02:04:51-04:00 0.5 https://investors.puretechhealth.com/news-releases/news-release-details/puretechs-founded-entity-gallop-oncology-present-new-data 2025-11-03T09:09:51-05:00 0.5 https://investors.puretechhealth.com/news-releases/news-release-details/puretechs-founded-entity-gallop-oncology-announces-positive 2025-12-05T13:06:44-05:00 0.5 https://investors.puretechhealth.com/news-releases/news-release-details/puretech-announces-successful-end-phase-2-meeting-fda 2025-12-08T02:19:26-05:00 0.5 https://investors.puretechhealth.com/news-releases/news-release-details/results-agm-june-16-2025-update-statement 2025-12-10T12:55:24-05:00 0.5 https://investors.puretechhealth.com/news-releases/news-release-details/puretech-appoints-robert-lyne-chief-executive-officer 2025-12-18T02:07:16-05:00 0.5 https://investors.puretechhealth.com/news-releases/news-release-details/puretech-present-44th-annual-jp-morgan-healthcare-conference 2026-01-06T07:05:24-05:00 0.5 https://investors.puretechhealth.com/news-releases/news-release-details/puretech-announces-orphan-drug-designations-granted-us-food-and 2026-02-19T12:56:56-05:00 0.5 https://investors.puretechhealth.com/news-releases/news-release-details/puretech-present-leerink-partners-global-healthcare-conference-0 2026-02-25T02:13:36-05:00 0.5 https://investors.puretechhealth.com/news-releases/news-release-details/puretech-founded-entity-seaport-therapeutics-announces-0 2026-03-25T15:23:36-04:00 0.5 https://investors.puretechhealth.com/news-releases/news-release-details/oral-allopregnanolone-prodrug-bypasses-liver-metabolism 2026-03-26T09:29:19-04:00 0.5 https://investors.puretechhealth.com/news-releases/news-release-details/puretech-announces-publication-phase-2b-elevate-ipf-trial 2026-04-02T08:15:23-04:00 0.5 https://investors.puretechhealth.com/news-releases/news-release-details/puretech-founded-entity-seaport-therapeutics-announces-positive 2026-04-02T07:06:58-04:00 0.5 https://investors.puretechhealth.com/news-releases/news-release-details/deupirfenidone-compared-pirfenidone-and-placebo-idiopathic 2026-04-02T14:24:06-04:00 0.5 https://investors.puretechhealth.com/sec-filings/sec-filing/20fr12b/0001193125-20-278627 2020-10-27T17:28:39-04:00 0.4 https://investors.puretechhealth.com/sec-filings/sec-filing/f-6/0001193805-20-001366 2020-11-02T17:28:43-05:00 0.4 https://investors.puretechhealth.com/sec-filings/sec-filing/drs/0000950123-20-009894 2020-11-03T00:20:11-05:00 0.4 https://investors.puretechhealth.com/sec-filings/sec-filing/20fr12ba/0001193125-20-288657 2020-11-09T10:37:27-05:00 0.4 https://investors.puretechhealth.com/sec-filings/sec-filing/effect/9999999995-20-003161 2020-11-13T06:11:13-05:00 0.4 https://investors.puretechhealth.com/sec-filings/sec-filing/6-k/0001193125-21-021507 2021-01-29T06:18:56-05:00 0.4 https://investors.puretechhealth.com/sec-filings/sec-filing/6-k/0001193125-21-029720 2021-02-05T07:25:08-05:00 0.4 https://investors.puretechhealth.com/sec-filings/sec-filing/6-k/0001193125-21-035138 2021-02-10T06:12:27-05:00 0.4 https://investors.puretechhealth.com/sec-filings/sec-filing/sc-13da/0001193125-21-035223 2021-02-10T06:20:16-05:00 0.4 https://investors.puretechhealth.com/sec-filings/sec-filing/sc-13g/0000914208-21-000319 2021-02-16T15:55:49-05:00 0.4 https://investors.puretechhealth.com/sec-filings/sec-filing/6-k/0001193125-21-080408 2021-03-15T06:34:09-04:00 0.4 https://investors.puretechhealth.com/sec-filings/sec-filing/6-k/0001193125-21-084745 2021-03-18T06:06:59-04:00 0.4 https://investors.puretechhealth.com/sec-filings/sec-filing/20-f/0001628280-21-006938 2021-04-15T08:41:29-04:00 0.4 https://investors.puretechhealth.com/sec-filings/sec-filing/6-k/0001193125-21-175344 2021-05-27T16:29:58-04:00 0.4 https://investors.puretechhealth.com/sec-filings/sec-filing/6-k/0001193125-21-218074 2021-07-19T07:33:51-04:00 0.4 https://investors.puretechhealth.com/sec-filings/sec-filing/6-k/0001628280-21-017514 2021-08-24T06:57:38-04:00 0.4 https://investors.puretechhealth.com/sec-filings/sec-filing/6-k/0001193125-21-296208 2021-10-12T06:12:27-04:00 0.4 https://investors.puretechhealth.com/sec-filings/sec-filing/6-k/0001193125-21-323665 2021-11-09T06:13:25-05:00 0.4 https://investors.puretechhealth.com/sec-filings/sec-filing/6-k/0001193125-21-325152 2021-11-10T06:13:09-05:00 0.4 https://investors.puretechhealth.com/sec-filings/sec-filing/6-k/0001193125-22-009222 2022-01-14T06:10:46-05:00 0.4 https://investors.puretechhealth.com/sec-filings/sec-filing/3/0000899243-22-002890 2022-01-21T16:32:13-05:00 0.4 https://investors.puretechhealth.com/sec-filings/sec-filing/6-k/0001193125-22-017648 2022-01-26T07:07:51-05:00 0.4 https://investors.puretechhealth.com/sec-filings/sec-filing/sc-13ga/0000914208-22-000236 2022-02-11T12:35:40-05:00 0.4 https://investors.puretechhealth.com/sec-filings/sec-filing/6-k/0001193125-22-083239 2022-03-24T06:12:17-04:00 0.4 https://investors.puretechhealth.com/sec-filings/sec-filing/6-k/0001193125-22-118693 2022-04-26T06:18:05-04:00 0.4 https://investors.puretechhealth.com/sec-filings/sec-filing/20-f/0001782999-22-000004 2022-04-26T06:56:53-04:00 0.4 https://investors.puretechhealth.com/sec-filings/sec-filing/6-k/0001193125-22-141192 2022-05-05T06:21:42-04:00 0.4 https://investors.puretechhealth.com/sec-filings/sec-filing/6-k/0001193125-22-144203 2022-05-09T07:38:22-04:00 0.4 https://investors.puretechhealth.com/sec-filings/sec-filing/6-k/0001193125-22-167331 2022-06-03T16:17:25-04:00 0.4 https://investors.puretechhealth.com/sec-filings/sec-filing/6-k/0001193125-22-174772 2022-06-15T16:17:47-04:00 0.4 https://investors.puretechhealth.com/sec-filings/sec-filing/6-k/0001193125-22-187955 2022-07-05T16:32:48-04:00 0.4 https://investors.puretechhealth.com/sec-filings/sec-filing/6-k/0001193125-22-212568 2022-08-04T16:39:39-04:00 0.4 https://investors.puretechhealth.com/sec-filings/sec-filing/6-k/0001193125-22-216197 2022-08-09T17:24:39-04:00 0.4 https://investors.puretechhealth.com/sec-filings/sec-filing/6-k/0001193125-22-226525 2022-08-22T16:53:49-04:00 0.4 https://investors.puretechhealth.com/sec-filings/sec-filing/6-k/0001782999-22-000009 2022-08-25T06:12:39-04:00 0.4 https://investors.puretechhealth.com/sec-filings/sec-filing/3/0000899243-22-030028 2022-08-29T21:35:38-04:00 0.4 https://investors.puretechhealth.com/sec-filings/sec-filing/sc-13d/0001193125-22-234155 2022-08-30T16:51:13-04:00 0.4 https://investors.puretechhealth.com/sec-filings/sec-filing/6-k/0001193125-22-237929 2022-09-02T16:22:15-04:00 0.4 https://investors.puretechhealth.com/sec-filings/sec-filing/6-k/0001193125-22-257620 2022-10-04T16:34:26-04:00 0.4 https://investors.puretechhealth.com/sec-filings/sec-filing/6-k/0001193125-22-259197 2022-10-07T07:02:48-04:00 0.4 https://investors.puretechhealth.com/sec-filings/sec-filing/6-k/0001193125-22-260192 2022-10-11T07:07:25-04:00 0.4 https://investors.puretechhealth.com/sec-filings/sec-filing/6-k/0001193125-22-276984 2022-11-03T16:58:25-04:00 0.4 https://investors.puretechhealth.com/sec-filings/sec-filing/6-k/0001193125-22-282683 2022-11-10T16:40:36-05:00 0.4 https://investors.puretechhealth.com/sec-filings/sec-filing/6-k/0001193125-22-297571 2022-12-02T16:33:35-05:00 0.4 https://investors.puretechhealth.com/sec-filings/sec-filing/6-k/0001193125-22-310469 2022-12-22T06:10:25-05:00 0.4 https://investors.puretechhealth.com/sec-filings/sec-filing/6-k/0001193125-23-023269 2023-02-03T06:12:22-05:00 0.4 https://investors.puretechhealth.com/sec-filings/sec-filing/sc-13ga/0000914208-23-000242 2023-02-10T06:17:48-05:00 0.4 https://investors.puretechhealth.com/sec-filings/sec-filing/6-k/0001193125-23-058242 2023-03-02T16:33:07-05:00 0.4 https://investors.puretechhealth.com/sec-filings/sec-filing/6-k/0001193125-23-074573 2023-03-20T11:51:10-04:00 0.4 https://investors.puretechhealth.com/sec-filings/sec-filing/6-k/0001193125-23-077225 2023-03-23T06:32:29-04:00 0.4 https://investors.puretechhealth.com/sec-filings/sec-filing/6-k/0001193125-23-090922 2023-04-04T16:32:38-04:00 0.4 https://investors.puretechhealth.com/sec-filings/sec-filing/6-k/0001193125-23-123947 2023-04-28T06:21:39-04:00 0.4 https://investors.puretechhealth.com/sec-filings/sec-filing/20-f/0001782999-23-000004 2023-04-28T07:34:07-04:00 0.4 https://investors.puretechhealth.com/sec-filings/sec-filing/6-k/0001193125-23-134451 2023-05-03T16:32:50-04:00 0.4 https://investors.puretechhealth.com/sec-filings/sec-filing/4/0000899243-23-012087 2023-05-03T16:32:58-04:00 0.4 https://investors.puretechhealth.com/sec-filings/sec-filing/4/0000899243-23-014169 2023-05-31T17:34:48-04:00 0.4 https://investors.puretechhealth.com/sec-filings/sec-filing/6-k/0001193125-23-159887 2023-06-02T16:33:37-04:00 0.4 https://investors.puretechhealth.com/sec-filings/sec-filing/6-k/0001193125-23-165346 2023-06-12T16:32:28-04:00 0.4 https://investors.puretechhealth.com/sec-filings/sec-filing/4/0000899243-23-015533 2023-06-14T16:32:20-04:00 0.4 https://investors.puretechhealth.com/sec-filings/sec-filing/6-k/0001193125-23-166899 2023-06-14T16:33:42-04:00 0.4 https://investors.puretechhealth.com/sec-filings/sec-filing/6-k/0001193125-23-182802 2023-07-06T16:32:45-04:00 0.4 https://investors.puretechhealth.com/sec-filings/sec-filing/6-k/0001193125-23-201753 2023-08-02T16:32:09-04:00 0.4 https://investors.puretechhealth.com/sec-filings/sec-filing/6-k/0001628280-23-030824 2023-08-29T06:39:32-04:00 0.4 https://investors.puretechhealth.com/sec-filings/sec-filing/6-k/0001193125-23-229661 2023-09-06T16:32:03-04:00 0.4 https://investors.puretechhealth.com/sec-filings/sec-filing/4/0000950170-23-049198 2023-09-21T16:33:07-04:00 0.4 https://investors.puretechhealth.com/sec-filings/sec-filing/6-k/0001193125-23-249960 2023-10-03T16:32:12-04:00 0.4 https://investors.puretechhealth.com/sec-filings/sec-filing/6-k/0001193125-23-269414 2023-11-02T16:35:18-04:00 0.4 https://investors.puretechhealth.com/sec-filings/sec-filing/6-k/0001193125-23-289189 2023-12-05T16:32:49-05:00 0.4 https://investors.puretechhealth.com/sec-filings/sec-filing/6-k/0001193125-23-299259 2023-12-20T06:31:49-05:00 0.4 https://investors.puretechhealth.com/sec-filings/sec-filing/6-k/0001193125-24-002462 2024-01-04T16:32:35-05:00 0.4 https://investors.puretechhealth.com/sec-filings/sec-filing/6-k/0001193125-24-024099 2024-02-05T16:32:15-05:00 0.4 https://investors.puretechhealth.com/sec-filings/sec-filing/sc-13ga/0000914208-24-000160 2024-02-12T16:50:08-05:00 0.4 https://investors.puretechhealth.com/sec-filings/sec-filing/6-k/0001193125-24-057956 2024-03-04T16:52:50-05:00 0.4 https://investors.puretechhealth.com/sec-filings/sec-filing/6-k/0001193125-24-070190 2024-03-18T16:34:50-04:00 0.4 https://investors.puretechhealth.com/sec-filings/sec-filing/6-k/0001193125-24-070817 2024-03-19T08:32:03-04:00 0.4 https://investors.puretechhealth.com/sec-filings/sec-filing/sc-c/0001193125-24-070822 2024-03-19T08:34:02-04:00 0.4 https://investors.puretechhealth.com/sec-filings/sec-filing/6-k/0001193125-24-090082 2024-04-09T06:32:24-04:00 0.4 https://investors.puretechhealth.com/sec-filings/sec-filing/6-k/0001193125-24-111455 2024-04-25T06:32:14-04:00 0.4 https://investors.puretechhealth.com/sec-filings/sec-filing/20-f/0001628280-24-017913 2024-04-25T12:10:28-04:00 0.4 https://investors.puretechhealth.com/sec-filings/sec-filing/sc-i/0001193125-24-142208 2024-05-20T07:09:52-04:00 0.4 https://investors.puretechhealth.com/sec-filings/sec-filing/6-k/0001193125-24-142883 2024-05-20T16:35:11-04:00 0.4 https://investors.puretechhealth.com/sec-filings/sec-filing/6-k/0001193125-24-149222 2024-05-29T16:34:50-04:00 0.4 https://investors.puretechhealth.com/sec-filings/sec-filing/sc-13da/0001193125-24-149863 2024-05-30T08:06:55-04:00 0.4 https://investors.puretechhealth.com/sec-filings/sec-filing/sc-ia/0001193125-24-153618 2024-06-04T07:02:52-04:00 0.4 https://investors.puretechhealth.com/sec-filings/sec-filing/6-k/0001193125-24-154301 2024-06-04T16:32:47-04:00 0.4 https://investors.puretechhealth.com/sec-filings/sec-filing/6-k/0001193125-24-156115 2024-06-06T16:33:11-04:00 0.4 https://investors.puretechhealth.com/sec-filings/sec-filing/sc-ia/0001193125-24-156134 2024-06-06T16:40:49-04:00 0.4 https://investors.puretechhealth.com/sec-filings/sec-filing/6-k/0001193125-24-160739 2024-06-13T16:35:08-04:00 0.4 https://investors.puretechhealth.com/sec-filings/sec-filing/6-k/0001193125-24-163983 2024-06-20T07:34:53-04:00 0.4 https://investors.puretechhealth.com/sec-filings/sec-filing/sc-ia/0001193125-24-166945 2024-06-24T16:12:54-04:00 0.4 https://investors.puretechhealth.com/sec-filings/sec-filing/6-k/0001193125-24-166986 2024-06-24T16:36:28-04:00 0.4 https://investors.puretechhealth.com/sec-filings/sec-filing/4/0000950170-24-082232 2024-07-08T19:46:45-04:00 0.4 https://investors.puretechhealth.com/sec-filings/sec-filing/sc-13da/0001193125-24-176581 2024-07-09T08:08:20-04:00 0.4 https://investors.puretechhealth.com/sec-filings/sec-filing/corresp/0001193125-24-153623 2024-07-24T00:07:20-04:00 0.4 https://investors.puretechhealth.com/sec-filings/sec-filing/upload/0000000000-24-006234 2024-07-24T00:07:20-04:00 0.4 https://investors.puretechhealth.com/sec-filings/sec-filing/6-k/0001193125-24-205384 2024-08-22T16:31:49-04:00 0.4 https://investors.puretechhealth.com/sec-filings/sec-filing/6-k/0001782999-24-000004 2024-08-28T07:32:20-04:00 0.4 https://investors.puretechhealth.com/sec-filings/sec-filing/6-k/0001193125-24-208848 2024-08-28T16:35:13-04:00 0.4 https://investors.puretechhealth.com/sec-filings/sec-filing/6-k/0001193125-24-227987 2024-09-27T16:32:39-04:00 0.4 https://investors.puretechhealth.com/sec-filings/sec-filing/6-k/0001193125-24-240439 2024-10-21T16:33:09-04:00 0.4 https://investors.puretechhealth.com/sec-filings/sec-filing/sc-13ga/0000914208-24-000465 2024-11-07T09:49:43-05:00 0.4 https://investors.puretechhealth.com/sec-filings/sec-filing/sc-13g/0000950170-24-125067 2024-11-12T13:30:52-05:00 0.4 https://investors.puretechhealth.com/sec-filings/sec-filing/6-k/0001193125-24-279047 2024-12-16T08:08:24-05:00 0.4 https://investors.puretechhealth.com/sec-filings/sec-filing/upload/0000000000-24-012702 2024-12-18T00:09:30-05:00 0.4 https://investors.puretechhealth.com/sec-filings/sec-filing/corresp/0001193125-24-236749 2024-12-18T00:09:42-05:00 0.4 https://investors.puretechhealth.com/sec-filings/sec-filing/upload/0000000000-24-010536 2024-12-18T00:09:54-05:00 0.4 https://investors.puretechhealth.com/sec-filings/sec-filing/0000950170-25-019025 2025-02-12T17:30:06-05:00 0.4 https://investors.puretechhealth.com/sec-filings/sec-filing/6-k/0001193125-25-074667 2025-04-07T16:16:07-04:00 0.4 https://investors.puretechhealth.com/sec-filings/sec-filing/6-k/0001193125-25-105602 2025-04-30T06:32:11-04:00 0.4 https://investors.puretechhealth.com/sec-filings/sec-filing/20-f/0001782999-25-000005 2025-04-30T10:49:50-04:00 0.4 https://investors.puretechhealth.com/sec-filings/sec-filing/6-k/0001193125-25-141445 2025-06-16T16:31:47-04:00 0.4 https://investors.puretechhealth.com/sec-filings/sec-filing/6-k/0001193125-25-156607 2025-07-08T16:18:32-04:00 0.4 https://investors.puretechhealth.com/sec-filings/sec-filing/6-k/0001193125-25-159538 2025-07-16T06:31:54-04:00 0.4 https://investors.puretechhealth.com/sec-filings/sec-filing/schedule-13g/0000950170-25-106382 2025-08-11T13:07:12-04:00 0.4 https://investors.puretechhealth.com/sec-filings/sec-filing/6-k/0001628280-25-041238 2025-08-28T06:50:27-04:00 0.4 https://investors.puretechhealth.com/sec-filings/sec-filing/6-k/0001193125-25-314304 2025-12-10T16:31:55-05:00 0.4 https://investors.puretechhealth.com/sec-filings/sec-filing/6-k/0001193125-25-323679 2025-12-18T07:07:13-05:00 0.4 https://investors.puretechhealth.com/board-member/daphne-zohar 2020-10-29T11:20:35-04:00 0.5 https://investors.puretechhealth.com/board-member/robert-horvitz-phd 2020-10-29T11:23:39-04:00 0.5 https://investors.puretechhealth.com/board-member/raju-kucherlapati-phd 2023-11-16T15:52:37-05:00 0.5 https://investors.puretechhealth.com/board-member/john-lamattina-phd 2020-10-29T11:25:29-04:00 0.5 https://investors.puretechhealth.com/board-member/robert-langer-scd 2020-10-29T11:26:20-04:00 0.5 https://investors.puretechhealth.com/board-member/kiran-mazumdar-shaw 2020-10-29T11:26:58-04:00 0.5 https://investors.puretechhealth.com/analyst/amy-walker 2022-01-06T16:00:21-05:00 0.5 https://investors.puretechhealth.com/sharon-barber-lui 2025-12-18T04:20:20-05:00 0.5 https://investors.puretechhealth.com/board-member/michele-holcomb-phd 2024-08-22T02:06:35-04:00 0.5